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Nathan J. VanDusen 
HAND2 FUNCTION WITHIN NON-CARDIOMYOCYTES REGULATES 
CARDIAC MORPHOGENESIS AND PERFORMANCE 
 
The heart is a complex organ that is composed of numerous cell types, 
which must integrate their programs for proper specification, differentiation, and 
cardiac morphogenesis. During cardiac development the basic helix-loop-helix 
transcription factor Hand2 is dynamically expressed within the endocardium and 
extra-cardiac lineages such as the epicardium, cardiac neural crest cells 
(cNCCs), and NCC derived components of the autonomic nervous system. To 
investigate Hand2 function within these populations we utilized multiple murine 
Hand2 Conditional Knockout (H2CKO) genetic models. These studies establish 
for the first time a functional requirement for Hand2 within the endocardium, as 
several distinct phenotypes including hypotrabeculation, tricuspid atresia, 
aberrant septation, and precocious coronary development are observed in 
endocardial H2CKOs. Molecular analyses reveal that endocardial Hand2 
functions within the Notch signaling pathway to regulate expression of Nrg1, 
which encodes a crucial secreted growth factor. Furthermore, we demonstrate 
that Notch signaling regulates coronary angiogenesis via Hand2 mediated 
modulation of Vegf signaling.  
Hand2 is strongly expressed within midgestation NCC and endocardium 
derived cardiac cushion mesenchyme. To ascertain the function of Hand2 within 
these cells we employed the Periostin Cre (Postn-Cre), which marks cushion 
mesenchyme, a small subset of the epicardium, and components of the 
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autonomic nervous system, to conditionally ablate Hand2. We find that Postn-Cre 
H2CKOs die shortly after birth despite a lack of cardiac structural defects. Gene 
expression analyses demonstrate that Postn-Cre ablates Hand2 from the adrenal 
medulla, causing downregulation of Dopamine Beta Hydroxylase (Dbh), a gene 
encoding a crucial catecholaminergic biosynthetic enzyme. Electrocardiograms 
demonstrate that 3-day postnatal Postn-Cre H2CKO pups exhibit significantly 
slower heart rates than control littermates. In conjunction with the 
aforementioned gene expression analyses, these results indicate that loss of 
Hand2 function within the adrenal medulla results in a catecholamine deficiency 
and subsequent heart failure. 
 





TABLE OF CONTENTS 
Chapter I: Heart Development Overview 
A. Introduction to Cardiogenesis…………………………………….…… 1 
B. Endocardium…………………………………………………………….. 4 
C. Neural Crest Cells………………………………………………………. 7 
D. Epicardium………………………………………………………………. 11 
E. Twist Family bHLH Factors……………………………………………. 12 
Chapter II: Hand2 Function in the Endocardium 
A. Introduction………………………………………………………………. 23 
B. Methods………………………………………………………………….. 25 
C. Results…………………………………………………………………… 31 
D. Discussion……………………………………………………………….. 68 
Chapter III: Hand2 Function in Neural Crest Cells 
A. Introduction………………………………………………………………. 81 
B. Methods………………………………………………………………….. 86 
C. Results…………………………………………………………………… 87 
D. Discussion……………………………………………………………….. 101 
Chapter IV: Conclusions and Future Directions………………………………... 106 







Heart Development Overview 
A. Introduction to Cardiogenesis and bHLH Transcription Factors 
The heart is a complex organ whose origins initiate from several 
mesodermal progenitor populations during early stages of embryonic 
development. The complete organ is composed of a number of cell types, which 
include an endothelial lining of the lumen (the endocardium), cardiomyocytes 
which provide the mechanical function of the pump, an outer epicardial layer, and 
neural crest cells (NCCs) which form the great arteries connecting the pump to 
systemic and pulmonary components of the vasculature. What follows is an 
overview of the cell types, developmental paradigms, and molecular mechanisms 
which underlie mammalian cardiogenesis.  
The complex process of cardiac development begins with the specification 
of the anterior lateral mesoderm, termed the cardiac crescent, which contributes 
to the first heart field (FHF) myocardium and a portion of the endocardium 
(Brand, 2003; Lyons, 1996; Olson and Srivastava, 1996; Prall et al., 2007; 
Sucov, 1998). These cells first undergo migration to the embryo midline to form a 
linear heart tube (Fig. 1). This heart tube is composed of two cell layers, an inner 
layer composed of endocardial (endothelial) cells and the outer being 
cardiomyocytes. The space between the layers is filled with extracellular matrix 
(ECM) commonly referred to as cardiac jelly. This substance is primarily 
composed of secreted molecules such as proteoglycans and 
glycosaminoglycans which provide structural support and facilitate cell-cell 
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communication  (DeLaughter et al., 2011). After initial heart tube formation, 
pharyngeal mesoderm that lies anterior to the cardiac crescent, which is termed 
the second heart field (SHF; yellow in Fig. 1 marks tissues that receive a SHF 
contribution), migrates into the heart tube from both the rostral and caudal ends, 
adding endocardium and myocardium to the now expanding heart (for review see 
Kelly, 2005; Nakajima, 2010; Vincent and Buckingham, 2010). As a consequence 
of the SHF cell contribution, the tube loops to the right and balloons to form 
common atrial and ventricular chambers, adjoined by a single common 
atrioventricular canal (AVC).  Further expansion and remodeling (accompanied 
by atrial, ventricular, and AVC septation) results in a four chambered heart 
complete with two distinct AVCs; the right AVC contains the tricuspid valve and 
the left the mitral valve. Similarly, cardiac outflow tract (OFT) cushions are 
invaded by migratory NCCs. Once populated, these cushions will septate the 






Figure 1: Cardiac Development 
Diagram of cardiac development. Ventricle, V; atria, A; right atria, RA; left atria, 
LA; outflow tract, OFT; atrioventricular valve, AVV; aorta, Ao; pulmonary artery, 
PA. FHF derived structures are colored in orange; tissues that the SHF 
contributes to are colored in yellow. 






The endocardium and myocardium both derive from the anterior lateral 
splanchnic mesoderm which forms the cardiac crescent (Fig. 1; Srivastava, 2006; 
Smith and Bader, 2007), and second heart field progenitors. The heart tube will 
grow and expand due to SHF and cardiac NCC (cNCC) contributions. Paracrine 
signaling originating from the myocardium induces endocardial cells in the future 
AV canal and outflow tract (OFT) to increase ECM synthesis, producing local 
swelling. These protrusions, termed cardiac cushions, are populated when a 
subset of endocardial cells undergo epithelial-to-mesenchymal transition (EMT) 
and invade. Conditional gene deletion studies, in addition to in vitro data, suggest 
that myocardial Bone Morphogenetic Protein (Bmp) production is the primary 
initiator of cardiac cushion formation. Mice lacking myocardial Bmp2 or 
endocardial Bmp receptor-1a expression exhibit defective EMT (Ma et al., 2005). 
Additional factors demonstrated to be necessary for endocardial EMT, including 
Notch1, Msx2, and members of the Tgfβ signaling pathway, are downregulated in 
models of aberrant Bmp signaling (Combs and Yutzey, 2009; Ma et al., 2005). 
Notch1 encodes a transmembrane receptor that acts as a crucial signaling 
component in a wide variety of cell types and organ systems. Genetic deletion of 
Notch1 or its functional partner RBPJk does not affect initial ECM deposition, but 
results in EMT failure (Timmerman et al., 2004). Endothelial deletion of cell-cell 
adhesion regulator β-catenin also results in EMT failure, implicating Wnt 
signaling in murine cardiac cushion formation. Post-EMT, the ECM and 
mesenchymal cells of the cushions are remodeled from their unorganized 
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primitive state into the highly ordered structures that constitute mature heart 
valves (Combs and Yutzey, 2009). Given the complex combination of EMT, ECM 
secretion, and remodeling that must occur in a precise spatiotemporal manner for 
correct valve development, it is not surprising that valve related deficiencies are 
present in a majority of all heart defects (Barnett and Desgrosellier, 2003).   
As the endocardial subset of cells undergoing EMT invades the cardiac 
cushions, signaling factors originating from the endocardium cue expansion and 
proper patterning of the myocardium. These factors operate within Vegf, Notch, 
Ephrin, Bmp, Wnt, and Neuregulin signaling (Armstrong, 2004), with extensive 
cross-talk between pathways. Current models suggest that activated Vegf 
receptors (VegfRs) initiate Notch signaling via upregulation of the Notch ligand 
Dll4 (Wythe et al., 2013). Endocardial Notch1 then activates endocardial 
production of the secreted growth factor Neuregulin1 (Nrg1) via direct regulation 
of EphrinB2 (EfnB2), a transmembrane ligand (Grego-Bessa et al., 2007). 
Significantly, specific mechanisms of Nrg1 regulation by Ephrin signaling have 
not been proposed. In addition to Nrg1 regulation, endocardial Notch1 also 
activates expression of myocardial Bmp10 through a poorly understood 
independent mechanism. Recent studies demonstrate that Nrg1 and Bmp10 
have unique but equally important roles in the process of trabeculation. Nrg1 
induces specification of the trabecular myocardium, and upon specification 
Bmp10 drives proliferation (Fig. 2). Genetic deletion of Notch1, EfnB2, Nrg1, or 
Bmp10 all result in loss of cardiac trabeculation (Chen et al., 2004; Grego-Bessa 




Figure 2: Notch signaling and trabeculation 
Schematic showing endocardial signaling events that direct myocardial 
trabeculation.  






C. Neural Crest Cells 
NCCs arise from ectoderm at the lateral edge of the neural plate, and 
extend along the dorsal aspect of the neural tube from the mid-diencephalon 
through the caudal portion of the developing embryo (Creazzo et al., 1998; 
Huang and Saint-Jeannet, 2004). These ectodermal cells are induced to undergo 
EMT by a combination of Wnt, Bmp, and Fgf signaling, resulting in delamination 
from the neuroepithelium and migration into the caudal pharyngeal arches 
(Huang and Saint-Jeannet, 2004). The cNCCs are a small vagal subpopulation of 
NCC which migrate into the heart (Stoller and Epstein, 2005). During heart 
development, cNCC populations make essential contributions via migration into 
the third, fourth, and sixth pharyngeal arches, where they will contribute to 
remodeling of the aortic arch arteries and cardiac outflow tract (Stoller and 
Epstein, 2005). Upon arrival, cNCC differentiate into smooth muscle cells and 
pericytes, which participate in septation of the embryonic OFT tract into 
pulmonary and aortic components (Kirby et al., 1983; Nelms and Labosky, 2010; 
Snider et al., 2007). Subsequently, the majority of neural crest derived cells in the 
aorticopulmonary septum undergo apoptosis (Poelmann and Gittenberger-de 
Groot, 1999). The remodeling of the aortic arch arteries is a complex 
programmed process involving the regression of some arterial structures and the 
persistence of others. Initially, each pharyngeal arch contains a symmetrically 
branched artery originating from the single vessel of the early OFT. Through the 
action of cNCC, this symmetrical arterial network is remodeled into the 
predominantly left sided vascular pattern seen in adults (Snider et al., 2007). This 
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coordinated regression has been associated with Tgfβ2 signaling, as Tgfβ2-/- 
mice display aberrant apoptosis in both fourth arch arteries, while lacking normal 
apoptosis in the right dorsal aorta (Molin et al., 2002). 
If a significant portion of the cNCC fail to reach the OFT, as a result of cell 
death or a defect in migration, a common congenital abnormality known as 
persistent truncus arteriosus (PTA) results. In PTA, the OFT fails to septate and 
results in a single large common vessel. The high incidence of PTA in congenital 
disorders such as Di George Syndrome implicates NCC dysfunction in the 
pathology of these diseases (Van Mierop and Kutsche, 1986).  Other NCC-
related OFT abnormalities include double outlet right ventricle (DORV) and 
overriding aorta.  These defects result from the incorrect alignment of the aorta 
with the left ventricle (LV). During proper alignment, the cardiac tube loops to 
bring the OFT (distal end) into close proximity with the inflow tract (proximal end). 
The OFT undergoes septation such that the newly formed aorta gets placed 
between the left and right AVC in a process called wedging, which ultimately 
results in correct alignment of the aorta over the developing LV and the 
pulmonary artery over the right ventricle (Allwork and Anderson, 1978; Kirby and 
Waldo, 1995). If wedging occurs incorrectly, the aorta is often displaced to the 
right, resulting in either DORV, where both the pulmonary artery and aorta are 
connected to the right ventricle, or in overriding aorta, where the aorta partially 
connects to each ventricle. Experimental evidence suggests that OFT septation 
must occur properly to avoid looping defects which result in improper wedging 
(Yelbuz et al., 2002). Indeed, the OFT septum in genetic models of cNCC 
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ablation is often either misaligned with the ventricular septum or incompletely 
developed (Creazzo et al., 1998).  
Although the processes of aortic arch artery and OFT remodeling are still 
not well understood, genetic loss-of-function models have revealed a number of 
proteins that are involved in the regulation of cNCC. These include the 
transcription factor Pax3, which is thought to play a role in NCC progenitor 
formation (Olaopa et al., 2011), the Wnt/Dvl downstream effector Pitx2 (Kioussi 
et al., 2002), and winged helix-turn-helix factor Ets1 (Gao et al., 2010). Loss of 
these factors results in aortic arch artery and OFT defects such as DORV, PTA, 
and transposition of the great arteries (TGA). While transcriptional regulation of 
the genes discussed above clearly affects cNCC movement and function, many 
other proteins in the surrounding environment have a non-cell autonomous role 
to play. For instance Tbx1, which is affected by a chromosomal deletion of 
22q11.2 causing Di George Syndrome, is not expressed in NCC, but can be 
found in tissue of the pharyngeal arches adjacent to NCC (Snider et al., 2007). 
Despite this fact, haploinsufficient mice display major defects in the development 
of the aortic arch arteries, indicating that cNCC take important cues relating to 
migration and morphogenesis from their environment (Garg et al., 2001; Hutson 
and Kirby, 2003; Snider et al., 2007). Indeed, the forkhead/winged helix 
transcription factors Foxc1 and Foxc2 are expressed in endothelial tissues 
surrounding NCCs and have been shown to be essential for proper OFT and 
arch artery morphogenesis (Hutson and Kirby, 2003). These factors most likely 
act through transcriptional regulation of secreted molecules, such as Endothelin-
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1, which is produced by endothelial cells neighboring NCCs (Kurihara et al., 
1995). Additional factors that mediate cell-cell signaling within NCC populations 
include the gap junction protein Connexin43 (Cx43; Reaume et al., 1995), the 
secreted ligand Semaphorin3c (Sema3C; Feiner et al., 2001), and its receptor 
Plexin A2 (Brown et al., 2001; Hutson and Kirby, 2003). Research on these 
factors has demonstrated the critical nature of cell-cell interactions and 
communication during cNCC development. While this fact is well appreciated, 
future studies are still needed to fully reveal and define regulatory mechanisms. 
Many cell types and structures including facial bones, the peripheral 
nervous system (PNS), and endocrine system receive heavy contributions from 
NCC and have been extensively reviewed (Creuzet, 2009; Gross and Hanken, 
2008; Heude et al., 2010; Wang et al., 2011). The autonomic nervous system 
(ANS), a branch of the PNS, is of particular importance, as its components have 
been demonstrated to regulate cardiac function (Kishi, 2012). The ANS is 
composed of sympathetic and parasympathetic neurons, as well as medullary 
cells of the adrenal gland. NCC sympathoadrenal precursors migrate ventrally 
from the neural tube towards the dorsal aorta, which coordinates NCC migration 
through the release of Bmp. Bmp in turn activates production of additional 
cytokines and growth factors, such as Stromal Cell-Derived Factor-1 (Sdf1) and 
Neuregulin1 (Nrg1), which regulate sympathoadrenal cell morphogenesis (Saito 
et al., 2012). This molecular cascade guides NCC migration, but also activates a 
poorly defined transcriptional program that drives the specification of the adrenal 
and sympathetic lineages. Once specified, neurons of the sympathetic ganglia 
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and cells of the adrenal medulla produce enzymes necessary for catecholamine 
biosynthesis. These include Tyrosine Hydroxylase (Th), the enzyme responsible 
for conversion of L-tyrosine to a dopamine precursor, Dopamine Beta 
Hydroxylase (Dbh), responsible for conversion of dopamine to norepinephrine, 
and Phenylethanolamine N-Methyltransferase (Pnmt), which converts 
norepinephrine to epinephrine. The catecholamines epinephrine and 
norepinephrine are then released into the bloodstream to regulate heart rate, 
blood pressure, blood vessel constriction, and other critical aspects of 
cardiovascular function (Axelrod and Reisine, 1984; Fung et al., 2008).  
 
D. Epicardium 
The epicardium originates from a cluster of cells at the venous pole of the 
heart termed the proepicardial organ (PEO). Due to a combination of Fibroblast 
Growth Factor (Fgf) and Bmp signaling, aggregates of cells from within the 
PEO’s mesothelial projections undergo an EMT event and migrate to the surface 
of the developing ventricles, ultimately covering the entire surface of the heart in 
a caudal to cranial fashion (Lie-Venema et al., 2007). In mice, this process is 
initiated by E9.0 and is complete by approximately E11.0 (Komiyama et al., 
1987). Once the epicardial cells have enveloped the heart, multiple waves of 
epicardial cells undergo a secondary EMT and migrate into the adjacent 
myocardium. Similar to cNCC EMT, this event is regulated by a combination of 
paracrine growth factors and proteins such as Slug, Snail, and E-cadherin, with 
good evidence for Ets1, Ets2, α4 integrin, and WT1 involvement (Lie-Venema et 
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al., 2007). Growth factors implicated in epicardial cell EMT include Fgf, Pdgf, 
Tgfβ, and Vegf (Morabito et al., 2001). Upon entering the myocardium, epicardial 
progenitor derived cells (EPDCs) are guided to their final destinations by 
signaling mechanisms that are not yet well understood, but are known to involve 
Pdgf-β, Pdgfrβ, Tbx5, Thymosin β4, and the Ets transcription factors. EPDCs will 
ultimately take up position in interstitial spaces of the ventricles and atria, 
contributing to the cardiac fibroblast lineage, smooth muscle of the coronary 
vasculature, and cardiac cushions (Lie-Venema et al., 2007). In chick, there is 
good evidence for EPDC contribution to the coronary endothelium (Perez-
Pomares et al., 2002), although this has not been substantiated in mice. While 
controversial, evidence also exists for limited EPDC contribution to the 
myocardium (Zhou et al., 2008).  
 
E. Twist Family bHLH Factors 
In humans, the bHLH superfamily is known to contain over 100 factors, 
which play crucial roles both during and after embryonic development, and in the 
etiology of many diseases (Jones, 2004). bHLH transcription factors share two 
common domains. The first is a motif consisting of basic residues that facilitate 
DNA binding to a canonical consensus sequence. Many variations in the 
consensus sequence have been demonstrated, depending on the specific bHLH 
factor, but CANNTG is a commonly bound sequence, and is termed an E-box. 
The second is the helix-loop-helix domain, which contains two amphipathic α-
helices separated by a loop of variable length. The HLH domains facilitate 
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dimerization via juxtaposition of the hydrophobic faces of the α-helices from two 
different bHLH proteins. Dimer formation allows for correct positioning of the two 
basic domains that directly bind DNA (for extensive bHLH review see Massari 
and Murre 2000). Of the hundreds of proteins which contain a bHLH motif 
(Atchley and Fitch, 1997) the Twist subclass of bHLH proteins is a small group of 
transcription factors that contain high amino acid identity, with particularly high 
conservation within the bHLH domain (Castanon and Baylies, 2002). In 
mammals, the Twist family of bHLH transcription factors is composed of six 
members: Twist1, Twist2, Hand1, Hand2, Paraxis, and Scleraxis; although 
homologs of these factors can also be found in phylogenetically distant species 
such as flies, flatworms, and jellyfish (Barnes and Firulli, 2009; Gitelman, 2007). 
While Twist proteins show great diversity in their expression profiles, and thus in 
the developmental processes they regulate, Twist family members have several 
key characteristics in common.  It is has been well established that Twist bHLH 
proteins functionally operate either as homodimers or heterodimers with other 
bHLH factors (Barnes and Firulli, 2009; Castanon and Baylies, 2002; Castanon 
et al., 2001; Firulli et al., 2000; Tapanes-Castillo and Baylies, 2004). 
Heterodimerization can occur with other Twist members, but also commonly 
involves non-Twist bHLH proteins, such as the ubiquitously expressed E-
proteins. Dimer partner choice has been shown to dictate factor function 
(Castanon et al., 2001; Firulli et al., 2003; Firulli et al., 2005; Firulli et al., 2007) 
and is affected by elements such as gene dosage, which can alter the ratio of 
Twist family proteins present within the transcription factor pool inside each cell. 
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Phosphoregulation also plays multiple roles in the regulatory process. The 
phosphorylation of conserved threonine and serine residues within the first -
helix of Twist family bHLH factors has been demonstrated to affect dimerization 
partner choice and therefore function. Phosphoregulation can also alter 
intracellular localization of Twist factors thus modifying dimer capacity (Barnes 
and Firulli, 2009; Firulli et al., 2003; Firulli et al., 2005; Firulli et al., 2007).  In 
order to understand the role Twist proteins play in developmental pathways such 
as cardiogenesis, these observations establish that one must define not only 
where and when the protein is expressed, but also understand the potential 
partners and post-translational modifications that collectively drive the formation 
of tissue-specific transcriptional complexes. 
 
Twist1 
Twist1 is a dynamic member of the Twist bHLH family, which is broadly 
expressed during development and marks the extra-embryonic, somitic, limb, 
and pharyngeal mesenchyme (Chen and Behringer, 1995; Fuchtbauer, 1995; 
Vincentz et al., 2008). Given this expression pattern, it is not surprising that 
genetic models reveal a role for Twist1 in regulating specification and 
differentiation in developing mesenchyme. Systemic deletion of Twist1 in mice 
results in embryonic lethality at E11.5 due to a spectrum of defects that include 
failure of the neural tube to close, defects in cranial mesenchyme, pharyngeal 
arches, somites, and limb buds (Chen and Behringer, 1995). This phenotype is 
consistent with a role for Twist1 in regulating mesenchyme morphology and 
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behavior during NCC migration and development. Furthermore, this correlates 
well with what is known about Twist1 function in neoplastic diseases, where a 
direct connection between elevated Twist1 expression and EMT has been found 
(Hoek et al., 2004). During EMT, epithelial cells lose polarity and take on an 
invasive phenotype via loss of cell adhesion due in part to a loss of the calcium 
dependent transmembrane protein E-cadherin, which is regulated by Twist1 as 
well as Snail and Zeb1 (Smit and Peeper, 2008). In the context of migratory 
cNCC, current evidence points to N-cadherin as a major mediator of EMT with 
Snail, Slug, Id2, and Pinch1 expression specifying EMT competence (Duband et 
al., 1995; Martinsen and Bronner-Fraser, 1998; Snider et al., 2007). It is not 
currently clear what role, if any, Twist1 plays in cNCC EMT. 
Upon close examination of Twist1-/- mice, it was discovered that the OFT 
cushions contain amorphic cellular nodules (Vincentz et al., 2008). Molecular 
analyses demonstrate that these nodules are of NCC origin and molecularly 
resemble ectodermal sympathetic ganglia. Further investigation subsequently 
revealed a role for Twist1 in the repression of pro-neural factors, such that Twist1 
regulates cell fate determination between ectodermal and mesodermal lineages 
within post-migratory NCC (Vincentz et al., 2013). In addition, Twist1 null mice 
are reported to exhibit a delay in colonization of the OFT cushions, as well as 
aberrant placement of NCC derivatives in the pericardium and endocardium. 
These data are consistent with research on Saethre Chotzen Syndrome (SCS), 
which is caused by TWIST1 mutations (Howard et al., 1997). These data 
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demonstrate that appropriate Twist1 dosage is essential for correct differentiation 
of cNCC, and suggest a role in guiding cNCC migration and cell adhesion.  
Twist1 is expressed in EPDCs undergoing EMT, but is not expressed 
within the epicardium (Zhou et al., 2010), and no epicardial functions have been 
reported. While not detectable in ventricular endocardium, Twist1 is robustly 
expressed in endocardial cushions of the AVC during murine mid-gestation, 
although this expression is down-regulated as the cushions are remodeled into 
valves. Indeed, by E17.5 Twist1 expression is either completely absent, or nearly 
so (Chakraborty et al., 2010). Loss-of-function and gain-of-function experiments 
in transduced chick endocardial cushion explants have revealed multiple roles for 
Twist1 during cushion formation and subsequent valve development. Twist1 can 
induce cell proliferation in these cushion explants, promote cushion migration, 
and affect differentiation marker genes (Shelton and Yutzey, 2008). These 
proposed functions correlate well with information gathered from persistent and 
overexpression of Twist1 in mice. In these studies a CAG-CAT-Twist1 transgene 
was induced by the endothelial specific Tie2-Cre, resulting in stable and 
persistent overexpression of Twist1 in the endocardium, and endocardium 
derived cushions (Chakraborty et al., 2010). Despite increases in area, length, 
and thickness of AV and OFT valve leaflets, double transgenic animals were 
viable. Detailed phenotypic analysis revealed abnormally high levels of 
proliferation in these valves, possibly due to a significant increase in Tbx20 
expression. Indeed, Tbx20 has previously been associated with proliferation via 
induction of N-myc (Cai et al., 2005). Twist1 overexpression was shown to affect 
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several ECM related genes, possibly accounting for phenotypic abnormalities in 
cushion remodeling and migration. Dysregulated genes include Col2a1, Mmp2, 
and Mmp13, and Postn – all of which are significantly upregulated (Chakraborty 
et al., 2010). Furthermore, a Col2a1 regulatory element is bound by Twist1 in 
vivo, and can be transactivated in vitro. This binding occurs at a conserved E-box 
in the Col2a1 first intron. Similarly, Twist1 has been demonstrated to be capable 
of binding an E-box in the Postn promoter and trans-activating a reporter 
construct (Oshima et al., 2002). This information correlates well with the 
increased levels of Postn expression observed at E17.5 in Twist1 overexpressing 
mice. Together, these results support a role for endocardial Twist1 in promoting 
proliferation of cardiac valve progenitors, and subsequently guiding their 




As the heart loops rightward, expression of Twist family member Hand1 is 
observed in the outer curvature of the left ventricle myocardium, as well as in the 
pericardium and septum transversum (Barnes et al., 2010; Cserjesi et al., 1995b; 
Firulli et al., 1998). During mid-gestation, Hand1 is expressed within the left 
ventricular myocardium, medial cNCC populating the caudal pharyngeal arches, 
and approximately 50% of the cNCC mesenchyme within the OFT cushions 
(Vincentz et al., 2011). Hand1 null mice die in utero at E9.5, due to defects in the 
yolk sac, placenta, vasculature, and heart (Firulli et al., 1998; Morikawa and 
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Cserjesi, 2004; Riley et al., 1998). Cardiac defects include failure of complete 
heart tube fusion and hypoplastic LV, which are likely secondary to placental, 
yolk sac and vascular defects. Conditional ablation of Hand1 within NCC does 
not reveal any developmental defects and may reflect a true functional 
redundancy with Hand2 in these cells (Barbosa et al., 2007). Indeed, NCC 
specific loss of Hand1 in Hand2+/- mice results in a dysregulation of Msx2, Pax9, 
and Prrx2 expression, as well as hypoplasia of certain pharyngeal arch derived 
structures such as the mandible. This again demonstrates the critical nature of 
gene dosage for the Twist family of bHLH factors (Barbosa et al., 2007). Given 
this data, it seems likely that interactions and redundancy with additional 
transcription factors may be masking an unknown role for Hand1 in cNCC 
development. 
Hand1 is not expressed within the PEO or epicardium but is expressed 
within the septum transversum that is directly caudal to the PEO. Interestingly, 
experiments using the Hand1eGFPCre allele in conjunction with R26R lineage 
mapping shows that the permanently-marked Hand1 expressing cells within the 
septum transversum migrate into the forming PEO and subsequently mark the 
entire epicardium, as well as secondary EMT epicardial-derived cell types such 
as the coronary smooth muscle, and cardiac fibroblasts (Barnes et al., 2010). 
Collectively, these experiments identify Hand1 as one of the earliest transcription 
factors that defines the epicardial lineage. Given the transitory expression of 
Hand1 in the early precursors of the PEO, it will be interesting to see what role, if 
any, it plays in the early specification and or migration of the epicardium. As a 
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tool, the Hand1eGFPCre allele allows for conditional gene recombination within the 
early epicardial lineage (Fig. 3). When this tool was employed to interrogate 
epicardial Hand2 function, several intriguing phenotypes were observed. These 
phenotypes included defective epicardialization, altered ECM secretion, and 
failure to form coronary arteries. For a detailed description of this study, as well 
as similar analyses utilizing both a tamoxifen inducible WT1ERT2Cre, and a 
transgenic WT1-Cre allele, see Appendix I. 
Hand1 is not expressed in the endocardium or endocardial cushions, and 
Hand1-lineage analysis shows no endocardial contributions of any cells that have 
expressed Hand1 (Barnes et al., 2010; Vincentz et al., 2011). However, 
myocardial specific ablation of Hand1 surprisingly results in hyperplastic 
endocardial cushions that mature into abnormally thick AV valves (McFadden et 
al., 2005). This would suggest that Hand1 is involved in a myocardium derived 
signaling pathway that regulates endocardial cushion cells. However, Bmp2, 
Bmp4, Smad6, Smad7, and Tgfβ expression levels are all normal in Hand1 
myocardial specific conditional knock outs (CKOs), leaving the details of such a 





Figure 3: Extracardiac Lineages 
Diagram of epicardial and cNCC lineage contributions to heart development (A). 
Epicardial lineage shown by lacZ staining of Hand1eGFPCre R26RZ/Z activation in 
right ventricle at E15.5 (B). Neural crest cell lineage, shown by lacZ staining of 
Wnt1-Cre; R26RZ/Z activation in OFT at E11.5 (C). PEO, proepicardial organ; 
OFT, outflow tract; RV, right ventricle; LV, left ventricle; cNCC, cardiac neural 




Paraxis, Scleraxis, and Twist2 
While Twist1 and Hand1 are established regulators of cardiac 
morphogenesis, less is known regarding the Twist family members Paraxis, 
Scleraxis (Scx), and Twist2. Although Paraxis is not expressed within the 
developing heart (Burgess et al., 1995), recent studies demonstrate that Scx 
plays an integral role in remodeling of the endocardium derived mesenchyme of 
the primitive valves. Scx is first expressed in mice at E9.5 in somites and 
mesenchyme of the body wall and limb buds. As the embryo matures this 
expression becomes restricted to areas of developing cartilage and connective 
tissue, including heart valves (Cserjesi et al., 1995a). Indeed, Scx-/- mouse 
embryos have thickened valve structures, increased expression of cartilage-
associated genes such as Sox9, Msx1, and Snail, and a disruption of ECM and 
collagen fiber organization. Conversely, overexpression of Scx in avian valve 
precursor cells and porcine adult valve interstitial cells results in increased 
secretion of chondroitin sulfate proteoglycans (Barnette et al., 2013). Further 
analyses revealed that Scx transcription is positively regulated by Tgfβ2 
signaling, while Mapk activity attenuates this activation. These observations have 
lead researchers to conclude that Scx is involved in valve precursor cell 
differentiation and ECM organization (Barnette et al., 2013; Levay et al., 2008). 
However, few direct transcriptional targets of Scleraxis have been identified 
(Espira et al., 2009; Liu et al., 1997), and the extent of its role in cardiogenesis is 
not well defined.  Additional investigation will be required to extend our current 
understanding. Twist2 is expressed within AV cushion mesenchyme during 
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midgestation cardiogenesis, and this expression is ectopically expanded to 
ventricular endocardium in mice that overexpress the Notch1 intracellular domain 
within the endothelial lineage. Twist2 function in cardiac development has not 









Hand2 Function within the Endocardium 
 
A. Introduction  
Hand2 is strongly expressed within ventricular endocardium and 
mesenchymal cells of the endocardial cushions during midgestation. However, 
no endocardial Hand2 functions have currently been defined. In Mef2c-Cre 
H2CKOs Hand2 is ablated from SHF cardiac progenitors, which contribute to 
both myocardium and endocardium. Mef2c-Cre H2CKO embryos display OFT 
septation defects, hypoplastic RV, and atresia of the tricuspid valve (tricuspid 
atresia, TA; Fig. 4), resulting in death at E13.5 (Tsuchihashi et al., 2011). As TA 
is not observed in myocardial H2CKOs (Morikawa and Cserjesi, 2008), and 
mesenchyme of the tricuspid valve is derived from the endocardium, these data 
suggest an important endocardial role for Hand2. We therefore hypothesized that 
loss of Hand2 function within the endocardium could be causative of a TA 
phenotype. Indeed, this study shows that conditional deletion of Hand2 (H2CKO) 
using both the endothelial specific Tie2-Cre and endocardial-specific Nfatc1-Cre 
results in loss of the tricuspid valve, hypotrabeculation, and altered septation 
which collectively resemble TA phenotypes. We show that endocardium to 
myocardium signaling is disrupted as Neuregulin1 (Nrg1) is dramatically 
downregulated within the endocardium of H2CKOs. Since Nrg1 is a known 
downstream component of Notch1 signaling, we examined additional 
components of the Notch pathway for expression level alterations. Our results 
show that Hand2 endocardial expression is Notch-dependent and that Hand2 is 
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downstream of both Notch1 and its direct target EphrinB2. Collectively, these 
data support a model whereby Notch signaling via Hand2 function within the 
endocardium allows for endocardial-myocardial cell communication that directly 
influences trabeculation and septal positioning/outgrowth. Subsequently, 
endocardial loss of Hand2 results in a consistently misplaced interventricular 
septum (IVS) that interferes with tricuspid valve development. As a consequence 
of this alteration in IVS position the RA and RV fail to make a direct connection, 
resulting in a TA phenotype. 
 
 
Figure 4: Tricuspid Atresia 





Mice and Genotyping 
Tie2-Cre(+) and Nfatc1-Cre(+) mice were crossed with Hand2+/- mice to 
generate Tie2-Cre(+);Hand2+/- and Nfatc1-Cre(+);Hand2+/- males (germline 
activation of Tie2-Cre occurs in females; de Lange et al., 2008). These males were 
then crossed with Hand2fx/fx;ROSA26R reporter mice (lacZ or eYFP) to generate 
conditional null Hand2 embryos. Tie2-Cre(+) females were crossed with EfnB2fx/fx 
males to generate Tie2-Cre(+);EfnB2fx/+ males. These males were then crossed with 
EfnB2fx/fx females to generate conditional null EfnB2 embryos. Twist1+/− and Wnt1-
Cre mice were obtained from the Jackson Laboratory. Postn-Cre(+) mice (Lindsley 
et al., 2007) were crossed with Hand2fx/fx (Morikawa et al., 2007) mice to generate 
Postn-Cre(+);Hand2fx/+ males. These males were then crossed with 
Hand2fx/fx;ROSA26R lacZ (R26Rz/z) reporter mice to generate conditionally null 
Hand2 embryos.  
For embryo generation female mice were checked daily for a semen plug, 
with the morning of detection being considered E0.5. Pregnant females were 
sacrificed at the desired stage, and embryos dissected out in cold PBS. Yolk sacs 
were collected for embryo genotyping. The cre-activatable transgene CAG-CAT-
Hand2 was constructed by replacing the Myc-Twist1 cDNA of CAG-CAT-Twist1 
(Connerney et al., 2006) with the murine Myc-Hand2 cDNA. This construct was 
used for microinjection to establish a transgenic line. CAGCAT-Hand2 and Cre 
genotyping of adult mice was achieved by southern blot on tail genomic DNA using 
a probe corresponding to the appropriate cDNA. For Hand2flox, Hand2 systemic, 
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EphrinB2flox, and Rosa genotyping, southern probes corresponding to the 
appropriate loci were utilized (Barnes et al., 2011; Gerety and Anderson, 2002). 
Genotyping for CAGCAT-Hand2(+) embryos was conducted by PCR using the 
Hand2 specific oligo 5’GGGATCCATCTGCCCAAGGACGACCAG 3’ and 
SV40PA(R). These primers were used with a denaturing temperature of 95°C for 30 
seconds, annealing temperature of 55°C for 60 seconds, and extension at 72°C for 
60 seconds, for 35 cycles. Mouse maintenance and experimentation was performed 
according to protocols approved by the Indiana University School of Medicine 
Institutional Animal Care and Use Committee.  
 
Histological Preparations 
For X-gal staining, embryos were dissected in PBS, fixed in 2% PFA plus 
0.2% glutaraldehyde for 20 minutes, rinsed in PBS, and incubated in X-gal staining 
solution overnight. Embryos were then post-fixed with 4% PFA for one hour, rinsed, 
and dehydrated through a graded series of ethanol dilutions, with 10 minutes in 
each dilution (50%, 70%, 90%, 95%, and 100% ethanol). Dehydrated embryos were 
incubated in a 1:1 citrosolv ethanol solution for 10 minutes, rinsed with 100% 
citrosolv twice for 10 minutes each, and embedded in paraffin for sectioning. 
Sections were counterstained with nuclear fast red. For alcian blue staining, 
embryos were dissected in PBS, fixed in 4% PFA for one hour, rinsed with PBT, and 
dehydrated through a graded series of methanol dilutions (25%, 50%, 75%, 100%) 
for 10 minutes in each dilution. Dehydrated embryos were rinsed in a 1:1 xylene 
methanol solution for 10 minutes, cleared with 100% xylene, and embedded in 
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paraffin. Paraffin was removed from sections using citrosolv. Sections were 
rehydrated, and stained with 0.15mg/ml Alcian Blue in 5% glacial acetic acid for 
30 minutes. Stained sections were rinsed with H2O, counterstained with nuclear fast 
red, and dehydrated with ethanol. Dehydrated sections were incubated in citrosolv 
for 15 minutes, and cover-slipped. 
 
Section RNA In Situ Hybridization 
This protocol was performed essentially as previously described (Vincentz et 
al., 2008). Embryos were dissected and embedded as for Alcian Blue staining. 
Embryos were sectioned at 10 microns, and paraffin was removed from sections 
using xylene. Sections were then rehydrated, digested in 10µg/mL Proteinase K for 
eight minutes, briefly rinsed in 0.2% glycine, and post-fixed for 10 minutes. Sections 
were then rinsed, incubated in 0.1M triethanolamine plus 1:400 acetic anhydride for 
20 minutes, and rinsed with PBS. Sections were then dehydrated with ethanol, and 
hybridized with antisense digoxygenin labeled riboprobes overnight at 70°C. 
Riboprobes were transcribed with T7, SP6, or T3 (Roche). After hybridization slides 
were washed in a 50% formamide, 1x SSC, 1% SDS solution for 1.25 hours at 
65°C. Slides were next washed with an STE solution containing 4x SSC, 20mM 
Tris-Cl (pH 7.5), 1mM EDTA for 10 minutes. Slides were then washed in STE again, 
with the addition of 0.02mg/mL RNAse (Life Technologies) for 30 minutes. After this 
incubation slides were rinsed once more with STE (no RNAse) for 10 minutes. All 
STE washes were conducted at 37°C. Slides were then rinsed twice in a maleic acid 
buffer solution (MABT) containing 0.1M maleic acid, 0.15M NaCl, and 0.1% Tween-
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20 (pH 7.5) for 30 minutes each, at room temperature. Slides were then placed in 
blocking solution composed of 0.08M maleic acid, 2% Boehringer Blocking Reagent, 
10% heat inactivated sheep serum, and 0.1% Tween-20 (pH 7.5) for two hours at 
room temperature. After blocking, slides were incubated with anti-DIG antibody 
(Roche) at a dilution of 1:2000 overnight at room temperature. Slides were than 
washed five times in MABT plus 2mM levamisole for 30 minutes each at room 
temperature. Slides were then washed for 5 minutes in a solution containing 0.1M 
NaCl, 0.1M TrisCl (pH 9.5), 0.05M MgCl2, and 0.1% Tween-20 at room temperature. 
Slides were then incubated in BM Purple AP substrate (Roche) until appropriate 
staining was achieved (generally 1-3 days).   
 
RNA Isolation and Quantitative RT-PCR 
Total RNA was isolated from individual flash-frozen E10.5 or E13.5 ventricles 
(AV canal to OFT), using the High Pure RNA Isolation Kit (Roche). Briefly, tissue is 
lysed, debris removed by centrifugation, RNA is purified by column, and DNA 
removed by DNase digestion. This RNA served as a template to generate cDNA 
using the Transcriptor First Strand cDNA Synthesis Kit (Roche). For quantitative RT-
PCR (qRT-PCR), cDNA was amplified using Taqman Probe-Based Gene 
Expression Assays (Applied Biosystems). Relative gene expression was determined 
after normalization to GAPDH. At least four samples were assayed per genotype at 
each time point. The Student’s t-test was used to detect significant differences 





Embryos were fixed in 2% PFA overnight, infused with 30% sucrose, 
cryoprotected, and sectioned at 10µm on a cryostat. Frozen sections were washed 
in PBS, blocked in 1.5% normal serum for one hour, and incubated with primary 
antibody overnight at 4˚C. Antibody staining for phospho-Histone H3 (pHistone H3; 
Abcam 47297), activated-Caspase 3 (aCaspase; Promega G748A), and Green 
Fluorescent Protein (GFP; Aves 1020) was conducted at a 1:500 dilution. Flk1 
immunostaining was conducted at a 1:50 dilution (Abcam 10972), while c-Myc 
immunostaining was conducted at a 1:200 dilution (Sigma C3956). Secondary 
antibodies were conjugated with Alexa 488 or 594 (Molecular probes). Images were 
collected on a Leica CTR 5000 microscope at standardized conditions with Leica 
Application Suite software. Cell-autonomous proliferation/death was calculated by 
counting cells displaying colocalization of GFP and pHistone H3/aCaspase, divided 
by total number of GFP(+) cells. Non cell-autonomous proliferation/death was 
calculated by counting all cells displaying pHistone H3/aCaspase expression, 
divided by total number of GFP(+) cells. All death and proliferation counts were 
generated from a minimum of 12 pairs of sections, obtained from two control 
embryos and two somite matched littermate H2CKO embryos. 
 
Electrophoretic mobility shift assays, luciferase assays, and chromatin 
immunoprecipitation 
Hand2 and E12 were in vitro translated using the Promega Reticulocyte 
Lysate System. 5µl of translated protein was incubated with radio-labeled oligos 
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corresponding to conserved E-boxes and D-boxes, in binding buffer for 30 
minutes at room temperature (Firulli et al., 2007). The following oligos and their 
compliments were utilized: Nrg1.D1, 5’-GCGAAGGAGGCGCCTGCGTCCAACT-
3’; Nrg1.D1m, 5’-GCGAAGGAGGGCACTGCGTCCAACT-3’; Nrg1.E2, 5’-AACTT
GCGGGCAATTGAAAAAGAGC-3’; Nrg1.E2m, 5’-AACTTGCGGGGCATTGAAA
AAGAGC-3’; Nrg1.E3, 5’-GCAGCGGCGGCAGCTGCCGGGAGAT-3’; 
Nrg1.E3m, 5’-GCAGCGGCGGGCACTGCCGGGAGAT-3’. Bold type signifies 
E/Dbox or corresponding mutagenized region. Transcription factor/oligo 
complexes were run out on a non-denaturing 6% polyacrylamide gel and 
assessed on a phospho-imager. For luciferase assays, HeLa cells were 
transfected using X-tremeGENE HP (Roche) at a ratio of 3:1 with Nrg1-
500bp+pGL4.10 (luciferase), pGL4.73 (renilla), Pcs2+Myc-Hand2, Pcs2+Myc-
E12, pcDNA+Myc-ΔBasic-Hand2 (kindly provided by Eric Olson), or pcDNA3.1 
and cultured for 48 hours. Cultures were harvested by scraping off cells in cold 
PBS and pelleting. Pellets were resuspended in 10x volume of passive lysis 
buffer (provided in Promega Dual Reporter Luciferase kit), frozen in liquid 
nitrogen, and thawed at 37°C. Luciferase and renilla reporter activity was 
assessed in 50ul of cell lysate using Luminoskan Ascent software and a 
ThermoLabsystems luminometer. Luciferase results were normalized to renilla 
(Holler et al., 2010), or protein lysate concentration. For chromatin 
immunoprecipitation (ChIP) of the Nrg1 promoter, HeLA cells were again 
transfected using X-tremeGENE HP at a ratio of 3:1. After culturing for 48 hours, 
cells were processed as previously described (Holler et al., 2010; Vincentz et al., 
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2012). Equal amounts of sheered chomatin were immunoprecipitated overnight 
at 4°C with 50µl of αMyc-conjugated agarose beads (Sigma), or beads without 
antibody for a negative control. After reversing crosslinks, eluted 
immunoprecipitated DNA was phenol chlorophorm extracted, resuspended in 
ddH2O, and used for subsequent PCR reactions. After 37 cycles of PCR 
amplification, product was analyzed on an agarose gel. ChIP primer pairs were 
as follows (forward, F; reverse, R): Nrg1-426F, 5’-GAGTTCCCCGAAACTTGT
TG-3’; Nrg1-324R, 5’-AGGTTATCACCGTCCTGCTC-3’; GAPDH(F), 5-CTG
CACCACCAACTGCTTAG-3; GAPDH(R), 5-CAGTGAGCTTCCCGTTCAG-3. 




Ablation of Hand2 within the endocardium  
To test the hypothesis that loss of endocardial Hand2 results in TA, we first utilized 
the endothelial cell-specific Tie2-Cre allele (Kisanuki et al., 2001).  Intercrossing 
Tie2-Cre with mice carrying the Hand2 conditional allele (Hand2fx) deletes Hand2 
within the Cre-expressing cells and their descendants. Tie2-Cre is expressed in all 
endothelial cells, including cells of the endocardium, and mesenchymal cells of the 
atrioventricular cushions (Kisanuki et al., 2001). Tie2-Cre expression initiates at 
E8.5 in a fraction of endothelial cells, and by E9.5 virtually all are Tie2-Cre lineage 
positive (Kisanuki et al., 2001).  Its activation proceeds the onset of endocardial 
Hand2 expression, which marks all endocardial cells by E8.5 (Barnes et al., 2011). 
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Hand2fx/fx;R26RZ/Z females were mated with Tie2-Cre(+);Hand2+/- males, and 
neonates were genotyped. No H2CKO mice were observed (n=58, Table 1). We 
therefore set up timed matings and collected embryos at E14.5. Live Tie2-Cre 
H2CKO embryos were identified at less than Mendalian ratios (Table 1), while most 
were dead and beginning to be resorbed (data not shown).  
 
  E10.5 E12.5 E14.5 Postnatal
Total  199  75 53 58
Cre(+)  98  38 20 26
Mutants 38 (41) 18 (16) 2 (9) 0 (11)
 
Table 1: Tie2-Cre H2CKOs die at E14.5 
Genotypic frequencies of embryos obtained from ♂Tie2-Cre; H2+/- x 




Hand2 deletion within the endothelium was first verified by in situ 
hybridization (ISH) at E10.5 (Fig. 5A, B). Subsequent examination of Tie2-Cre 
H2CKO whole mount (Fig. 5D, E) and section histology (Fig. 5G, H) revealed 
hypotrabeculation and a highly penetrant TA phenotype comparable to that 
observed in the SHF Mef2c-Cre Hand2 mutants (Tsuchihashi et al., 2011). At E12.5 
we observe hypotrabeculation, ventricular septal defects (VSDs), and varying 
degrees of RV hypoplasticity in Tie2-Cre H2CKO hearts. Rightward septal 
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displacement and, occasionally (~20%), a double inlet left ventricle (DILV) 
phenotype was also observed (Fig. 5J). DILV is a CHD that closely resembles TA 
(Kim et al., 2001). 
To examine atrioventricular (AV) cushion formation, cell density, and 
extracellular matrix (ECM) deposition, tissue sections were stained with alcian blue. 
Although comparison of H2CKO cushions with those of controls reveals no 
difference in general size, or amount of ECM (Fig. 5K, L), there does appear to be a 
minor cushion positioning defect (asterisk in Fig. 5L).  Despite normal AV cushion 
size and ECM deposition, no direct connection between the RA and RV is detected 
in any plane of section, resulting in a single left sided AV canal in most H2CKOs 
(Fig. 5H).  
We recently have shown that the Hand1-lineage contributes to caudle 
vascular endothelium (Barnes et al., 2010). While no defects were observed in the 
yolk sac vasculature of Tie2-Cre H2CKOs (Fig. 6A-B), Hand2 may play critical 
roles in vascular endothelium that could contribute to the observed embryonic 
lethality of Tie2-Cre H2CKO embryos. Therefore, we used the endocardial-specific 
Nfatc1Cre allele (Wu et al., 2012) to generate H2CKOs (Fig. 5C, F, N). Similar to the 
Tie2-Cre, the Nfatc1Cre initiates expression throughout the endocardium at E9.0 (Wu 
et al., 2012). 
Nfatc1Cre H2CKOs showed dramatic defects in trabeculation, malformed IVS, 
and in most cases (~70%), atresia of the tricuspid valve (Fig. 5F, H, N). Interestingly, 
in some cases IVS malformations included abnormally large protrusions of 
myocardium that appear to indicate the formation of multiple IVSs (Fig. 5N). 
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Together, these data confirm that conditional deletion of Hand2 within the 
endocardium is critical for normal trabeculation and septation. Given that these 
phenotypes are myocardial in nature, this suggests that endocardial Hand2 plays a 






Figure 5: Endocardial deletion of Hand2 results in a VSD, hypotrabeculation, 
hypoplastic RV, and tricuspid valve abnormalities akin to the human CHD 
tricuspid atresia. 
Hand2 ISH of RV section from E10.5 control, Tie2-Cre H2CKO, and Nfatc1Cre 
H2CKO, respectively (A-C). Wholemount view of E12.5 control heart, Tie2-Cre 
H2CKO, and Nfatc1Cre H2CKO, respectively (D-F). R26R lacZ stained sections 
from E12.5 Tie2-Cre(+) control embryo (G), Tie2-Cre H2CKO with tricuspid 
atresia (H). R26R lacZ stained E12.5 Tie2-Cre(+) control embryo (I), and Tie2-
Cre H2CKO with double inlet left ventricle (J). R26R lacZ stained sections from 
E12.5 Nfatc1Cre control embryo (M), and Nfatc1Cre H2CKO (N). Alcian blue 
staining of E12.5 Tie2-Cre(+) control AV cushions (K), and Tie2-Cre H2CKO (L). 
Asterisk denotes abnormalities in AV cushion shape and position. SAVC, 
superior atrioventricular cushion; IAVC, inferior atrioventricular cushion;  






Figure 6: Development of the yolk sac vasculature and septation of the OFT 
occur normally in H2CKOs.  
H2CKOs lack yolk sac vasculature defects (A-C) which have been reported in 
systemic Hand2 knock outs. Black arrows denote large yolk sac vessels. H2CKOs 
do not exhibit PTA (D-F), which has been reported in other conditional Hand2 loss of 





In addition to cardiac defects, systemic deletion of Hand2 in mice results in 
severe yolk sac vasculature defects by E9.5. We show that yolk sac vascularization 
occurs normally in endocardial H2CKOs (Fig. 6A-C), supporting previous 
conclusions that Hand2 is required only within smooth muscle of the yolk sac 
vasculature (Yamagishi et al., 2000). Similarly, a key feature distinguishing 
endocardial-H2CKO embryos from Mef2c-Cre or other SHF-H2CKO embryos is the 
absence of outflow tract (OFT) defects. The OFTs of Mef2c-Cre H2CKOs fail to 
septate by E12.5 (Tsuchihashi et al., 2011), whereas OFT septation is clearly 
evident in endocardial-H2CKOs at this stage (Fig. 6D-F). This is a significant 
observation, as it suggests that SHF progenitor cell death is not causative of the TA 
phenotype, as we would also expect to see OFT defects if this was the case.  To 
confirm this hypothesis we tested for apoptosis in the pharyngeal mesoderm by 
immunostaining for activated Caspase-3. Results show no significant changes in 
apoptosis within the SHF progenitors of H2CKOs and controls (P-value = 0.498, Fig. 
7A) suggesting further that a specific endocardial Hand2 function causes the 
observed TA phenotype. 
While it is clear that endocardial H2CKO embryos develop a hypoplastic RV, 
we sought to determine at which stage this phenotype becomes apparent. Tie2-Cre 
control and H2CKO littermates were collected at E10.5, and direct RV cell counts 
using DAPI stained nuclei were performed. DAPI(+) nuclei from every sixth section 
of the RV were counted, and a p-value of 0.003 was calculated, indicating a 
significantly smaller RV (by ~23%) in H2CKOs (Fig. 7B). Having ruled out a loss of 
progenitor cell contribution from the E9.5 pharyngeal mesoderm, two possible 
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explanations for this reduction in RV size in H2CKOs are apparent: either an 
increase in the rate of RV cell death, or a decrease in the rate of RV cardiomyocyte 
proliferation. To address the possibility of an increase in cell death in developing 
H2CKO mutant hearts, we immunostained E10.5 frozen sections with α-activated 
Caspase-3 and α-GFP antibodies to identify cells of the Cre-lineage undergoing 
apoptosis. A total of 20 pairs of comparative RV sections were counted, and neither 
a cell-autonomous effect on apoptosis (p-value: 0.705, Fig. 7C), nor a non cell-
autonomous effect (P-value: 0.734, data not shown) was observed. Cell proliferation 
was analyzed in a similar fashion with an α-phospho-histone H3 (PHH3) antibody. 






Figure 7: H2CKOs develop a hypoplastic RV and larger LV, but do not show 
significant differences in cell death or proliferation.  
Cell death in control and Tie2-Cre H2CKO E9.5 pharyngeal mesoderm was 
measured by quantification of active-Caspase-3(+) cells. No difference was detected 
(A). Hypoplastic RV at E10.5 in Tie2-Cre H2CKOs was confirmed by counting 
DAPI(+) RV nuclei (B). Cell death was measured in control and Tie2-Cre H2CKO 
E10.5 RV by quantification of active-Caspase-3(+) cells. No difference was detected 
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(C). Cell proliferation in the E10.5 RV was determined by counting PHH3(+) cells. No 
difference was detected between control and H2CKO hearts (D). Ventricle area 





Loss of Hand2 alters the position of the IVS, blocking connection between the 
RA and RV 
Given these data, and the observation that both Tie2-Cre and Nfatc1Cre 
H2CKOs exhibit abnormalities of IVS position, we investigated whether an aberrant 
rightward positioning of the IVS simply reduces RV size, and thus would increase LV 
size. To test this hypothesis, we measured ventricular areas from four sections from 
each of three H2CKO embryos, and matched control sections. All sections were 
from E10.5 littermates, and area measurements were obtained using Adobe 
Photoshop. Results show that the area of H2CKO RVs is significantly smaller (P-
value = 8*10-4) by approximately 13%, while LVs are significantly larger (P-value = 
1*10-4) by approximately 19%. There is no significant difference in total ventricular 
area (P-value = 0.1730, Fig. 7E). Thus, H2CKO TA phenotypes appear to be the 
result of abnormal growth and positioning of the IVS. 
 
Hand2 controls Nrg1 expression within the endocardium 
We next investigated the changes in gene expression within H2CKOs using 
ISH. First we analyzed myocardial gene expression. The stress sensor gene Anf, 
and bHLH Twist family member Hand1 showed no observable change in expression 
(Fig. 8A-D). The AV canal marker Bmp2, cushion mesenchyme markers Pdgfra, 
Twist1, the T-box transcription factor Tbx20, and Gata4 also show no change in 
expression between mutants and controls suggesting that endothelial cushion EMT 
is largely unaffected (Fig. 8E-N).  In addition to these markers, expression analysis 
of Fog2 was of interest, as Fog2 deficient mice also display a tricuspid atresia 
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phenotype (Svensson et al., 2000). However, no change in Fog2 expression was 
observed (Fig. 9A, B). Deletion of TgfβR2 from the endothelium results in DILV (Jiao 
et al., 2006).  Analysis of TgfβR2 expression revealed no differences between 
H2CKO and controls (Fig. 9C, D). Although not comprehensive, these analyses 
suggest that cell growth, cell death, myocardial, and endocardial EMT transcriptional 
programs are not significantly affected in H2CKOs, and that Hand2 is not regulating 
Fog2.  
Notch signaling is known to be essential for proper trabeculation (Grego-
Bessa et al., 2007). To better ascertain the etiology of the hypotrabeculation 
phenotype observed in H2CKOs we examined Notch pathway gene expression. We 
first looked at the expression of the Notch-regulated bHLH transcriptional repressors 
(and potential Hand2 dimer partners; Firulli et al., 2000) Hey1 (Fig. 9E, F) and Hey2 
(Fig. 9G, H) finding that endocardial expression was not significantly changed. Next 
we examined expression of the direct Notch1 target EphrinB2 (EfnB2; Grego-Bessa 
et al., 2007). EfnB2 ISH showed no change in expression between H2CKOs and 
control embryos (Fig. 10A-D). However, EGF family member Neuregulin1 (Nrg1) is 
markedly downregulated at E10.5 within the endocardium of H2CKOs (Fig. 10E-H). 
Nrg1 is a growth factor that is produced in the endocardium and is known to be a 
major mediator of trabeculation in the developing ventricles. Nrg1 is dramatically 
downregulated in Tie2-Cre Notch1 CKOs, and EfnB2 systemic null embryos (Grego-
Bessa et al., 2007). The maintenance of EfnB2 and loss of Nrg1 in H2CKOs 
suggests that Hand2 may act downstream of EfnB2, but upstream of Nrg1, 
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Figure 8: Additional markers analyzed in Tie2-Cre H2CKOs  
Unchanged Anf (A, B) and Hand1 (C, D) expression indicates normal patterning of 
the left ventricle in H2CKOs. Unchanged Bmp2 (E, F) expression indicates proper 
formation of AVC myocardium. Unchanged Pdgfra (G, H), Twist1 (I, J), Tbx20 (K, L), 
and Gata4 (M, N) expression indicates that EMT and early endocardial cushion 








Figure 9: ISH RV images of tricuspid atresia and Notch1 related marker 
expression in Tie2-Cre H2CKOs at E10.5.  
Unchanged expression of Fog2 (A, B) and TgfβR2 (C, D) in H2CKOs indicates that 
endocardial loss of Hand2 function is a novel cause of tricuspid atresia. Unchanged 
expression of Notch1 targets Hey1 (E, F), Hey2 (G, H), indicate normal Notch1 





We next analyzed Bmp10 expression, as Bmp10 is also crucial for proper 
trabeculation, is independently downstream of Notch1 signaling (Grego-Bessa et al., 
2007), and represents a clear link to myocardial communication from the 
endothelium (Chen et al., 2004; Chen et al., 2006).  BMP10 ISH at E10.5 suggested 
a small downregulation in H2CKOs (Fig. 9I, J) while E12.5 ISH showed a near 
complete loss of Bmp10 expressing trabecular tissue within the RV (Fig. 10I, J). To 
confirm that Bmp10 expression is reduced, we then dissected out ventricles from 
E10.5 hearts, and isolated RNA for qRT-PCR. As expected, qRT-PCR analysis 
confirms that both Hand2 and Nrg1 are significantly downregulated in H2CKOs (Fig. 
10K). However, the decrease in Bmp10 expression is not statistically significant (Fig. 
10K). The more dramatic loss of Bmp10 within the RV of E12.5 H2CKOs reflects 
well the absence of RV trabeculation (Fig. 10J). In addition to trabeculation, we 
further hypothesize that the formation and positioning of the IVS is regulated by this 
Hand2-dependent endocardium to myocardium signaling, which is necessary for the 
formation of a patent connection between the RA and RV via the tricuspid valve. 
 
Endocardial Hand2 functions downstream of Notch1 and the direct Notch1 
target EfnB2 
 The transmembrane receptor Notch1 is a crucial factor during cardiogenesis. 
Upon interaction with an extracellular ligand the Notch1 intracellular domain (NICD) 





Figure 10: H2CKOs exhibit down-regulation of Nrg1, followed by loss of Bmp10 
expressing trabecular tissue.  
Expression of the Notch1 target EfnB2 is unchanged in H2CKOs at E10.5 when 
compared to controls (A-D). Nrg1 expression at E10.5 is decreased in H2CKOs when 
compared to controls (E-H). H2CKOs have less Bmp10 expressing trabecular 
myocardium in the RV at E12.5 (I, J). qRT-PCR on isolated ventricles confirms the 
reduction of Nrg1 in E10.5 H2CKOs, as well as demonstrates that the majority of 
ventricular Hand2 expression at E10.5 is endocardial. EfnB2 and Bmp10 expression 
is unaltered at E10.5 (K). 
48 
 
 its partner RBPJk to activate transcription of target genes. Previous studies have 
shown that deletion of Notch1 or RBPJk results in hypotrabeculation due to loss of 
EfnB2 and Nrg1 (Grego-Bessa et al., 2007). To confirm that Hand2 lies within the 
Notch1 signaling pathway, we assayed Hand2 expression in E9.5 RBPJk-/- (Oka et 
al., 1995) embryos. Whole-mount analyses reveal a loss of cardiac Hand2, while 
expression within the OFT and pharyngeal mesenchyme is unaffected (Fig. 11A, B). 
Sectioned embryos revealed a specific loss of Hand2 within mutant endocardium 
(Fig. 11C, D), definitively establishing its role as a Notch1 signaling effector.  
During trabeculation NICD directly transactivates EfnB2, which acts through 
its EphB2/EphB4 tyrosine kinase receptors to upregulate Nrg1 (Grego-Bessa et al., 
2007). While our data clearly show Hand2 to be upstream of Nrg1 in the Notch1 
trabeculation pathway, it was not clear if Hand2 lies downstream of EphrinB2 
signaling, or if Hand2 represents an EfnB2 independent parallel Notch signaling 
pathway. To address this problem we acquired EfnB2fx/fx mice (kindly provided by 
Dr. Thomas Coate), and assayed Hand2 expression in E9.5 Tie2-Cre(+);EfnB2fx/fx 
embryos. ISH shows that Hand2 is downregulated in endocardial cells of Tie2-
Cre(+);EfnB2fx/fx embryos (Fig. 11F arrow), while Hand2 expression in pharyngeal 
mesenchyme and the proepicardial organ is unaffected when compared to Tie2-
Cre(-);EfnB2fx/+ control hearts (Fig. 11E). qRT-PCR analysis at E10.5 confirms 
Hand2 downregulation within Tie2-Cre(+);EfnB2fx/fx isolated hearts (n = 3, Fig. 11G). 
Together, these data show that Hand2 is a Notch-dependent endocardial factor 
positioned between EfnB2 and Nrg1 in the transcriptional pathway controlling 





Figure 11: Hand2 functions downstream of Notch1 and the direct Notch1 
target EphrinB2 during trabeculation.  
Wholemount Hand2 ISH in wild type (A) and RBPJk systemic knockout embryos 
(B). Arrows indicate cardiac Hand2 expression (A) and loss of expression (B). 
Section Hand2 ISH (C) revealed a downregulation of Hand2 within endocardium 
(arrows) of RBPJk systemic knockout hearts (D). Section Hand2 ISH (E) revealed a 
downregulation of Hand2 in Tie2-Cre EfnB2 CKO hearts (F). Arrows indicate 
endocardium; PM, pharyngeal mesenchyme; PEO, proepicardial organ. qRT-PCR 
on isolated ventricles confirmed that endocardial ablation of EfnB2 results in a loss 






Hand2 regulation of Nrg1 is direct via a 250bp Nrg1 promoter sequence 
ISH and qRT-PCR data clearly shows that Hand2 functions upstream of Nrg1 
(Fig. 10K). As Hand2 encodes a transcription factor with a similar expression profile 
to Nrg1, we sought to determine if Hand2 regulation of Nrg1 is direct. Although there 
are three distinct isoforms of Nrg1, Nrg1 type one has been shown to be the 
predominant Neuregulin in cardiovascular development (Meyer et al., 1997), and 
was the focus of our analysis.  Sequence corresponding to the Nrg1 promoter was 
downloaded from Ensemble Genome Browser for several mammalian species, and 
aligned using ClustalW. As Hand2 binds the consensus sequence CANNTG, 
termed an E-box, or alternatively CGNNTG, a D-box, we searched the aligned 
promoter for conserved E-boxes and D-boxes. Three were found within 500bp of the 
Nrg1 translation start site (Fig. 12A), a region previously identified as part of an 
850bp promoter necessary for high Nrg1 transcriptional activity in vitro (Frensing et 
al., 2008). To test if Hand2 directly interacts with this region of the Nrg1 promoter, 
we conducted ChIP assays in HeLa cells. As antibodies to endogenous Hand2 
have proven to be problematic, we employed a Myc-tagged Hand2 cotransfected 
with a plasmid encoding an untagged version of the Hand2 dimerization partner 
E12. Negative controls included Myc-Hand2 + E12 immunoprecipitated with 
beads only (no αMyc added), and Pcs2+Myc samples immunoprecipated with 
αMyc. Enrichment of the Nrg1 promoter region was assessed by semiquantitative 
PCR using primers corresponding to a 103bp region from -426 to -324 of the 
human Nrg1 promoter. This amplicon, which showed robust enrichment within 
Myc-Hand2 + E12 immunoprecipitated samples (Fig. 12B), is within 70bp or less 
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of all three conserved consensus sites. To confirm that Hand2 E12 heterodimers 
are capable of binding the conserved consensus sequences, radio-labeled oligos 
corresponding to these sites were used in electrophoretic mobility shift assays 
with in vitro translated Hand2 and E12. Hand2 E12 heterodimers were found to 
interact with oligos corresponding to sites 1 and 3, and this interaction could be 
considerably decreased by addition of excess unlabeled WT oligo (Fig. 12C, D). 
In contrast, addition of an excess of unlabeled mutant oligo had no effect on the 
interaction. No interaction was observed between Hand2 E12 complexes and an 
oligo corresponding to site 2. To test if Hand2 is capable of trans-activating the 
Nrg1 promoter, Hand2 and E12 expression constructs were transfected into 
HeLa cells along with a Nrg1 luciferase reporter containing the 1000bp upstream 
of the murine Nrg1 translation start site. A pGL4.74 renilla reporter was used as 
an internal control. Co-transfection of Hand2 and E12 resulted in reporter 
activation of approximately 7 fold. Furthermore, subsequent assays utilizing 
truncated 500bp (-500/0) and 250bp (-500/-250) promoters demonstrated even 
greater activation (~18 fold and 16 fold respectively; Fig. 12E). Transactivation 
data from the 500bp promoter reveal that E12 alone is not sufficient for 
activation, while Hand2 alone results in only mild transactivation. Consistent with 
EMSA results, co-transfection of Hand2 and E12 results in robust transactivation, 





Figure 12: Hand2 directly regulates Nrg1 via the 500bp Nrg1 promoter 
Sequence alignments reveal three Hand2 consensus sites (E-boxes and D-boxes) 
that are highly conserved among mammals (A). ChIP of the NRG1 promoter. H2 
indicates Hand2 transfection (B). EMSAs for sites 1 (C) and 3 (D) show robust and 
specific binding of Hand2 E12 heterodimers. No binding observed for site 2. 
Luciferase reporter assays with Nrg1 promoters of varying length. Red numbers 
indicate Hand2 consensus sites, green arrows indicate transcription start sites, and 
black arrows indicate approximate location of human ChIP primers (E). 
Transactivation of luciferase reporter containing the 500bp Nrg1 promoter. Error 
bars denote standard error; asterisks denote significant difference from control. (F). 
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Replacement of Hand2 within EfnB2 deficient endocardium results in a 
rescue of cardiac trabeculation 
EfnB2 mutant embryos display hypotrabeculation accompanied by loss of 
Hand2 and Nrg1 expression. The aforementioned analyses establish that Hand2 
directly regulates Nrg1. Therefore, if Hand2 is both necessary and sufficient for 
regulation of Nrg1, we reasoned that Hand2 replacement in Nfatc1Cre EfnB2 
CKOs would restore Nrg1 expression and improve the level of ventricular 
trabeculation. To this end, we generated a Cre-activatable Hand2 transgene 
(CAG-CAT-Hand2). This allele was generated by replacing the Twist1 cDNA of 
the CAG-CAT-Twist1 vector (Connerney et al., 2006) with a Hand2 cDNA. In the 
unrecombined state, the CMV enhancer/chicken beta-actin (CAG) promoter 
drives expression of chloramphenicol acetyltransferase (CAT). CAT and a 
downstream stop codon are flanked by loxP sites in such a way that 
recombination removes CAT, resulting in CAG promoter driven expression of the 
Hand2 transgene. In this way, Cre-dependent tissue specific overexpression of 
Hand2 can be achieved (Fig. 13A). 
Established models of limb development have demonstrated that ectopic 
expression of Hand2 in limb mesenchyme results in preaxial polydactyly (Firulli et 
al., 2005). As predicted, Prx1-Cre mediated activation of CAG-CAT-Hand2 within 
limb mesenchyme results in polydactyly, indicating that the transgene can be 
efficiently and specifically activated by Cre (Fig. 13B). Similarly, αMyc 
immunohistochemistry on sections of Wnt1-Cre(+); CAG-CAT-Hand2(+) embryos 
reveals activation of the Hand2 transgene in the expected neural crest cell 
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populations (Fig. 13C), and Nfatc1Cre efficiently activates CAG-CAT-Hand2 in the 
endocardium (Fig. 13D). E13.5 Nfatc1Cre; CAG-CAT-Hand2(+) embryos are 
present at Mendelian ratios and do not display any obvious cardiac phenotypes 
(data not shown). Subsequently, CAG-CAT-Hand2(+) males were crossed with 
EfnB2fx/fx females to generate CAG-CAT-Hand2(+); EfnB2fx/+ females. These 
females were then crossed with Nfatc1Cre; EfnB2fx/+ males to generate Nfatc1Cre; 
CAG-CAT-Hand2(+); EfnB2 CKOs (n = 3). CAG-CAT-Hand2(-) EfnB2 CKOs die 
by E11.5, with severe pericardial edema, hemorrhaging, and defects in cardiac 
looping and chamber development (Fig. 14). These phenotypes closely resemble 
the defects previously observed in Tie2-Cre EfnB2 CKOs (Gerety and Anderson, 
2002), indicating that while EfnB2 function within extracardiac vasculature is 
likely important, loss of endocardial EfnB2 is causative of the observed mid-
gestation lethality. Hand2 ISH at E10.5 confirms robust endocardial Hand2 
expression in controls (Fig. 15E, and F), and loss of Hand2 in EfnB2 CKOs (Fig. 
15G arrow). The presence of the CAG-CAT-Hand2 allele restores Hand2 
expression within the EfnB2 CKOs (Fig. 15H arrow). Nrg1 ISH reveals robust 
expression in controls (Fig. 15I, and J), and loss of Nrg1 expression in EfnB2 
CKOs (Fig. 15K arrow). CAG-CAT-Hand2(+) EfnB2 CKOs display an increase in 
Nrg1 expression (Fig. 15L, arrow), while assessment of trabeculation by Bmp10 
ISH reveals an increase in Bmp10 expressing trabecular myocardium (Fig. 15P 





Figure 13: Construction and validation of CAG-CAT-Hand2 allele 
Schematic of CAG-CAT-Hand2 transgenic allele (A). Activation of CAG-CAT-Hand2 
with Prx-Cre results in polydactyly. Toes are numbered (B). Rostral section from 
E11.5 Wnt1-Cre(+); CAG-CAT-Hand2(+) embryo that exhibits exencephaly (yellow 
arrow). αMyc immunohistochemistry marks Hand2 transgene expressing neural 
crest cells in green (C; white arrow). Transverse section of E14.5 Nfatc1Cre; CAG-
CAT-Hand2(+) heart. αMyc immunohistochemistry marks Hand2 transgene 







Figure 14: Nfatc1Cre H2CKOs die by E11.5 with severe cardiac defects 
Control embryo (A). Nfatc1Cre EfnB2 CKO embryos are smaller than controls, and 
display severe pericardial edema and heart looping defects (B, C). R26R lacZ 







Figure 15: Activation of a CAG-CAT-Hand2 transgene in Nfatc1Cre EfnB2 CKOs 
partially rescues phenotype and Nrg1 expression. 
  Wholemount images of E10.5 control, CAG-CAT-Hand2(+) control, mutant, and 
rescued mutant embryos (A-D). Section Hand2 ISH (E-H). Arrow in G indicates loss 
of Hand2, arrow in H indicates endocardial activation of CAG-CAT-Hand2. Section 
Nrg1 ISH (I-L). Arrow in K indicates loss of Nrg1; arrow in L indicates increased 
Nrg1 expression. Section Bmp10 ISH (M-P). Arrow in O indicates Bmp10 
expressing myocardium and lack of trabeculation; arrow in P indicates restoration of 




Notch signaling regulates coronary angiogenesis 
Early embryonic lethality in genetic models of dysfunctional notch 
signaling has precluded an in vivo assessment of the role of Notch signaling in 
formation of the coronary arteries. As we have established Hand2 as an integral 
component of endocardial Notch signaling, and as coronary endothelium has 
recently been reported to be derived at least in part from the endocardium (Wu et 
al., 2012), the survival of H2CKOs to E14.5 allows us a unique opportunity to 
assess Notch function in early coronary development. Analysis of hearts at 
E13.5, one day after initiation of intramyocardial coronary formation (Tian et al., 
2013), shows that Nfatc1Cre H2CKO hearts (Fig. 16B, magnification D) have an 
increased density of primitive coronary vessels when compared to control 
ventricles (Fig. 16A, magnification C). To ascertain the underlying mechanism of 
this hypervascularization, we analyzed genes associated with vascular 
development in E10.5 and E13.5 isolated ventricles by qRT-PCR (n = 4, Fig. 16E 
and F respectively). As expected, expression levels of Hand2 and Nrg1 are down 
at both time points. Has2, which encodes an enzyme responsible for the 
production of hyaluronan, an ECM component necessary for trabeculation, was 
also downregulated at both E10.5 and E13.5 (down 33%, P-value = 0.004; down 
54%, P-value = 8*10-4 respectively). Analysis of vascular markers at E10.5 
reveals dysregulation of select components of Vegf signaling (Fig. 16E). VegfR2 
and the VegfR2 co-receptor Nrp1 are downregulated by 30% and 14% 
respectively (P-value: 0.001 and 0.048, respectively), while VegfD, which 
encodes a VegfR3 specific ligand, is downregulated by 25% (P-value = 0.029). 
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By E13.5 expression levels of VegfR2 and VegfD have recovered (Fig. 7F), while 
Nrp1 remains modestly downregulated (P-value = 1.0*10-4). Surprisingly, 
expression of VegfA, which encodes the primary Vegf ligand that regulates 
vascular development (Ferrara et al., 1996), is upregulated by over 200% (P-
value: 0.013). Similarly, expression of VegfR3 is upregulated by 120% (P-value = 
0.044), while expression of Dll4, which encodes a notch ligand regulated by 
VegfRs (Wythe et al., 2013), is upregulated by approximately 85% (P-value = 
0.039). Differential regulation of several additional key vascular factors was also 
observed at E13.5. The venous markers CouptfII and EphB4 are downregulated 
by 21 and 24% respectively (P-value = 0.022, and 0.001 respectively), while the 
arterial marker EfnB2 is downregulated by 33% (P-value = 0.002). Surprisingly, 
Sox18 and Lyve1, which encode factors typically associated with endothelium of 
the lymphatic system (Banerji et al., 1999; François et al., 2008), were 
upregulated by 45% and 73% respectively (P-value = 0.003 and 0.044 
respectively). To determine what cardiac cell populations this additional 
expression of lymphatic associated factors was originating from, we conducted 
Lyve-1 immunostaining at E10.5 (Fig. 16G, H) and E13.5 (Fig. 16I-N) in control 
and H2CKO hearts. Sections were co-stained with VegfR2 to mark cardiac 
endothelium. E10.5 immunostaining reveals that Lyve-1 is expressed throughout 
the ventricular endocardium of both control and H2CKO hearts. In contrast, by 
E13.5 Lyve-1 immunostaining in control hearts is restricted to peripheral 
endothelium which will give rise to the cardiac lymphatic system (Fig. 16I), while 
robust Lyve-1 immunostaining persists in the ventricular endocardium of 
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H2CKOs (Fig. 16J, L). However, while Lyve-1 marks E13.5 ventricular 
endocardium of H2CKOs (Fig. 16N white arrow), Lyve-1 expression does not 







Figure 16: Hand2 controls coronary development and endocardial maturation 
via regulation of vegf signaling 
R26R lacZ stained E13.5 hearts (A, B). LV outer curvature of R26R lacZ stained 
hearts (C, D). Nfatc1Cre H2CKOs display hypervascularization. qRT-PCR analysis of 
E10.5 and E13.5 gene expression in Nfatc1Cre H2CKOs (E, F). Asterisks denote a 
statistically significant difference between control and H2CKO expression levels (n = 
4). Lyve-1 immunostaining in E10.5 Control and Tie2-Cre H2CKO hearts (G, H). 
Lyve-1 immunostaining in E13.5 Control and Nfatc1Cre H2CKO hearts (I-N). In 
control hearts Lyve-1 expression is restricted to endothelial lymphatic precursors by 
E13.5 (K), while H2CKOs continue to express Lvye-1 within ventricular endocardium 
(white arrow in L). Persistent Lyve-1 expression marks ventricular endocardium 
(white arrow in N) but not coronary endothelium (yellow arrow in N).   
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Ablation of Hand2 in endocardium derived cushion mesenchyme 
During cardiac development a subset of Hand2 expressing endocardial cells 
undergo EMT and populate the AV cushions. Hand2 expression is initially 
maintained in these mesenchymal cells, which will remodel to form the mature 
valves. However, Hand2 function in AV cushion mesenchyme has not been 
investigated. As both Nfatc1Cre and Tie2-Cre H2CKOs die before the organization 
of the mature valves can be evaluated, an alternative Cre recombinase is 
needed. The enhancer controlling Periostin Cre (Postn-Cre) activity is reportedly 
induced at approximately E10.5 within mesenchymal cells of the AV cushions, 
but not within ventricular endocardium (Lindsley et al., 2007), making the Postn-
Cre ideal for this experiment. Therefore, the Postn-Cre was utilized to selectively 
ablate Hand2 from valve mesenchyme. Timed matings between Postn-
Cre(+);Hand2fx/+ males and Hand2fx/fx;R26Rz/z females were conducted and the 
embryos collected at various time points from mid-gestation to birth. As Postn-
Cre activity was evident by E11.5, hearts from E12.5 embryos were used to 
compare Cre lineage to Hand2 expression. As expected, -galactosidase 
staining within the E12.5 heart robustly marks the AV cushion mesenchyme 
(black arrow Fig. 17A), as well as a small population of cells within the 
epicardium from which a population of cardiac myofibroblasts are derived. Hand2 
in situ hybridizations (ISH) similarly confirm that Hand2 expression overlaps with 
Postn-Cre lineage within AV valve mesenchyme, but Postn-Cre lineage does not 
overlap with Hand2 expression within the endocardium (Fig. 17A-C). Hand2 ISH 
of H2CKO embryos shows significant Postn-Cre-mediated deletion of Hand2 
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within AV cushions (asterisks in Fig. 17C), in contrast to unaffected Hand2 





Figure 17: Postn-Cre mediated deletion of Hand2 from AV cushions.  
Transverse section of Postn-Cre(+) lacZ stained control AV cushion at E12.5 (A). 
Hand2 ISH of control (B) and H2CKO (C) AV cushion. Black arrows indicate 
cushion mesenchyme; brown arrows indicate tricuspid and mitral valves. Asterisk 





Table 2: Postn-Cre H2CKOs die shortly after birth 
Genotypes and numbers of embryos collected at various stages of development. 





Postn-Cre H2CKOs are viable at birth, but die within the first 10 days of 
life (Table 2). A small portion of Hand2fx/fx pups die from cleft palate (Fig. 18); 
however, the occurrence of the palate defect is independent of the presence of 
the Cre allele, and results from hypomorphic expression, which has been 
previously reported with this Hand2 conditional allele (Morikawa et al., 2007). To 
determine whether H2CKOs exhibit AV valve phenotypes, E18.5 hearts were 
sectioned and analyzed by alcian blue staining, which marks proteoglycans 
within the heart valves (Fig. 19A, B). No significant differences in size or shape 
between control and H2CKO AV valves are observed. Furthermore, alcian blue 
staining reveals comparable proteoglycan levels and distribution in control (Fig. 
19A) and H2CKO valves (Fig. 19B). E18.5 Hand2 ISH reveals that Hand2 
expression is restricted to the endocardium overlying AV canal valves, and is not 
detectable within the valve mesenchyme of either control (Fig. 19C) or H2CKO 
(Fig. 19D) leaflets. ISH shows no significant difference in expression of the ECM 
component Postn within the mesenchymal cells of the cushions of control (Fig. 
19E) and H2CKO (Fig. 19F) embryos. These data indicate that Hand2 has no 







Figure 18: Hand2fx/fx mice have low penetrance cleft palate. 
Wholemount picture of Hand2fx/+ (A) and Hand2fx/fx (B) palate with lower jaw 
dissected away. Alcian blue stained transverse sections of Hand2fx/+ (C) and 
Hand2fx/fx (D) palate. Arrows in (B) and (D) indicate cleft. Primary palate, 1˚; 







Figure 19: Postn-Cre H2CKO AV valves are normal at E18.5. 
Alcian blue stained section of E18.5 control (A) and H2CKO (B) tricuspid valve 
(TV). Hand2 ISH of control (C) and H2CKO (D) tricuspid valve. Postn ISH of 






Loss of Hand2 within a pool of progenitors that originate in the pharyngeal 
mesenchyme and give rise to both endocardium and myocardium has been 
associated with TA (Tsuchihashi et al., 2011). In this study we show that loss of 
Hand2 specifically in the endocardium, a cell population where robust Hand2 
expression has previously gone uninvestigated, also results in TA. While we 
cannot rule out the possibility that loss of Hand2 within a subpopulation of SHF 
derived myocardium would also result in a TA phenotype, the absence of TA in 
the myocardial cTnT-Cre H2CKOs (Morikawa and Cserjesi, 2008), as well as 
SHF Islet1-Cre and Tbx20-Cre H2CKOs (Tsuchihashi et al., 2011) suggests this 
is unlikely. In addition, our data show that Hand2 plays an important role in Notch 
dependent endocardium to myocardium signaling, and this signaling regulates 
trabeculation as well as septal position and morphogenesis. Indeed, severe 
myocardial abnormalities in E13.5 H2CKOs include large muscular protrusions 
that resemble multiple septums. These myocardial protrusions express the septal 
marker Irx2 and compact zone/septal marker Hey2, while excluding expression 
of the trabecular marker Anf (Fig. 20). These data suggest that Hand2 balances 
the specification of trabecular and septal myocardium from primitive myocardium. 
Our results indicate that Hand2 influences myocardial identity through regulation 
of the secreted factor Nrg1. These results are consistent with previous reports 
that mice lacking either Nrg1 or the Nrg1 receptor ErbB2 do not develop 
trabecular myocardium (Lee et al., 1995; Meyer and Birchmeier, 1995). 
Furthermore, E12.5 embryonic hearts homozygous for an allele encoding a DNA 
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binding deficient form of Hand2 are reported to be hypotrabeculated with a 




Figure 20: A subset of Nfatc1Cre H2CKOs displays multiple septums, which are 
marked by Hey2 and Irx2. 
Wholemount images of E13.5 control and Nfatc1Cre H2CKO hearts (A-B). Hey2 
section ISH of control and Nfatc1Cre H2CKO at E13.5 (C-D). Anf section ISH of 
control and Nfatc1Cre H2CKO at E13.5 (E-F). Irx2 section ISH of control and 
Nfatc1Cre H2CKO at E12.5 (G-H). Arrow heads denote septal tissue.  
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While it is clear that endocardial loss of Hand2 impairs the Notch 
dependent processes of trabeculation and septal development, it is less clear 
how this impairment results in TA. It is possible that multiple morphogenic factors 
contribute to the TA observed in H2CKOs. Previous studies have concluded that 
TA occurs when the atrial connection to the AV canal expands rightward, but the 
ventricular inner curvature fails to remodel (Kim et al., 2001). Given the dramatic 
myocardial defects observed in H2CKOs, Hand2 dependent endocardial to 
myocardial signaling almost certainly regulates the remodeling of AV canal 
myocardium at some level; however, histological analysis of H2CKOs suggests 
that a rightward shifted septum fuses with cushion and RV myocardium in such a 
way that further development of the primitive right AV canal is blocked. 
Regardless, this study conclusively shows for the first time that endocardial 
dysfunction resulting from ablation of Hand2 can result in TA.  
In addition to identifying Nrg1 as a downstream target of Hand2, we also 
identify two upstream regulators. By demonstrating a loss of Hand2 in 
endocardium lacking RBPJk or EfnB2 we identify Hand2 as a crucial downstream 
effector of endocardial Notch signaling. While EfnB2 is reported to be directly 
activated by Notch1, it is not clear how EfnB2 and its receptor tyrosine kinase 
EphB4 regulate Hand2 expression. To address this mystery, an attempt to locate 
the Hand2 endocardial enhancer and characterize its responsiveness to Ephrin 
signaling is underway. Our finding that endocardial Hand2 is a Notch effector 
correlates well with previous reports that TA is among the range of phenotypes 
observed in the Notch effector Hey2 systemic mutants (Donovan et al., 2002; 
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Sarkozy et al., 2005). Interestingly, while we show Hey2 expression to be 
unaffected in E10.5 H2CKOs, Hand2 is reported to be markedly downregulated 
in Hey1/Hey2 double knockout embryos (Kokubo et al., 2005). Furthermore, as 
E-box binding bHLH factors co-expressed within the endocardium, the additional 
possibility that Hand2 and Hey factors are dimerization partners further 
complicates data interpretation. In fact, a recent ChIP-Seq study of Hey binding 
sites within transduced HEK-293s indicated that both Hey1 and Hey2 interact 
with the 500bp Nrg1 promoter (Heisig et al., 2012). Furthermore, assessment of 
Nrg1 expression in Hey2 knockout and Hey1/3 double knockout E14.5 ventricles 
revealed approximately 3 fold and 2.5 fold increases, respectively. While we do 
not observe any synergy or antagonism between Hand2 and Hey factors in Nrg1 
trans-activation assays (data not shown), the possibility that these factors act in a 
complex combinatorial fashion in vivo cannot be ruled out.  
During development Nrg1 is expressed throughout the arterial 
vasculature, while Hand2 expression in extracardiac endothelial cells has not 
been reported. Interestingly, Hand2 ISH at E10.5 does reveal expression within 
endothelium of the dorsal aorta, while expression within the cardinal vein is 
absent (Fig. 21B, C). This expression profile closely resembles that of Nrg1 (Fig. 
21D, E), and is consistent with reports that Notch is expressed in arterial 
endothelium, but not venous endothelium (Villa et al., 2001). These data suggest 
that Hand2 may play an important role in Nrg1 regulation within an arterial subset 





Figure 21: Hand2 and Nrg1 are co-expressed within the dorsal aorta. 
Schematic showing plane of section for panels B-E (A). Hand2 ISH in wild-type 
E10.5 embryo (B); box represents panel (C). Black arrow indicates Hand2 
expression in endothelium of the dorsal aorta, red arrow indicates lack of 
expression within endothelium of the cardinal vein. Nrg1 ISH in wild-type E10.5 
embryo (D). Box represents panel (E). Black arrow indicates Nrg1 expression in 
endothelium of the dorsal aorta, red arrow indicates lack of expression within 





To determine if Hand2 is independently sufficient to drive Nrg1 
expression, or if Ephrin signaling utilizes additional downstream effectors to 
cooperatively regulate Nrg1, we attempted to rescue Nrg1 expression and 
trabeculation in Nfatc1Cre EfnB2 CKOs using a Cre activatable Hand2 transgene 
(CAG-CAT-Hand2). CAG-CAT-Hand2(+) EfnB2 CKOs displayed markedly 
improved trabeculation, as visualized by Bmp10 ISH, and increased expression 
of Nrg1. However, while Nrg1 expression was increased, it was not restored to 
control levels, and rescued mutants still displayed hallmarks of cardiovascular 
failure such as pericardial edema. These results indicate that Hand2 is a crucial 
component of Nrg1 regulation that is sufficient to drive at least low levels of Nrg1 
expression; however, Ephrin signaling appears have additional inputs into Nrg1 
expression, and almost certainly modulates cardiovascular development via 
mechanisms independent of both Hand2 and Nrg1. Our observation that 
approximately 37% of Nrg1 expression remains in Tie2-Cre H2CKOs (Fig. 10K) 
while less than 10% remains in Tie2-Cre EfnB2 CKOs (Fig. 11G), supports this 
notion. 
While Hand2 has long been appreciated as a regulator of ventricular 
morphogenesis, we demonstrate for the first time that proper development of the 
primitive coronary vasculature is dependent on endocardial Hand2 expression. 
The exact origins of the coronary endothelium are still being debated (see Zhang 
and Pu, 2013 for review), but recent data indicate that the coronary plexus forms 
by angiogenesis (Red-Horse et al., 2010; Wu et al., 2012), and the endocardium 
makes an important contribution (Wu et al., 2012). Although dramatic defects in 
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myocardial morphogenesis can be observed in H2CKOs, histological analyses at 
E13.5 also reveal endocardial phenotypes. H2CKOs display precocious and 
disorganized development of the coronary vascular plexus. Analysis of vascular 
related gene expression in E10.5 and E13.5 H2CKOs by qRT-PCR surprisingly 
reveals that nearly all of the major components of cardiac Vegf signaling are 
differentially expressed. VegfR2 and VegfD are downregulated at E10.5, while 
VegfR3 and VegfA are significantly upregulated by E13.5. Additionally, VegfR2 
co-receptor Nrp1 is downregulated at both E10.5 and E13.5, while expression of 
the notch ligand Dll4 is increased at E13.5. Other genes differentially expressed 
in E13.5 H2CKOs include the venous markers CouptfII and EphB4 
(downregulated), as well the lymphatic associated marker Sox18 (upregulated). 
Interestingly, EfnB2 is moderately downregulated at E13.5, possibly indicating 
the presence of a Hand2 feedback loop. VegfA is the most upregulated gene in 
our dataset, and as VegfA is well known for its pro-angiogenic qualities (Ferrara 
et al., 2003; Gerhardt et al., 2003), these molecular analyses correlate well with 
the observed hyper-vascularization phenotype. Furthermore, qRT-PCR and 
immunostaining reveals elevated expression of the receptor Lyve-1 within 
endocardium of E13.5 H2CKOs. Analysis at E10.5 demonstrates that Lyve-1 is 
initially expressed throughout the endocardium, and is subsequently suppressed, 
such that by E13.5 strong expression is no longer visible within ventricular 
endocardium, but only within inflow tract derived peripheral endothelial cells that 
will give rise to the cardiac lymphatic system. Given the early endocardial 
expression of Lyve-1, this persistence within H2CKOs most likely represents a 
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defect in endocardial maturation, rather than ectopic activation of the lymphatic 
gene program. Of the genes we observed to be differentially expressed in E13.5 
H2CKOs, only Nrp1 is also downregulated at E10.5. Nrp1 encodes an isoform 
specific VegfA receptor that acts in concert with VegfR2 (Soker et al., 1998). 
Interestingly, an RNA subtractive hybridization screen previously identified Nrp1 
as being downregulated in Hand2 systemic null embryos (Yamagishi et al., 
2000). Our data demonstrate that Nrp1 is an endocardial target of Hand2, 
although regulation may also occur in additional tissues such as smooth muscle. 
Expression of VegfR3 is upregulated in E13.5 H2CKOs by over 100%. VegfR3 is 
capable of functioning as both a homo-dimer and VegfR3-VegfR2 hetero-dimer, 
and distinct functions have been associated with different interactions (Dixelius et 
al., 2003). VegfR3 has been demonstrated to play crucial roles in angiongenic 
sprouting and development of the lymphatic system (Benedito et al., 2012; 
Veikkola et al., 2001). Given that we have established Hand2 as a downstream 
effector of Notch signaling, and Notch reportedly regulates expression of VegfRs 
(Herbert and Stainier, 2011), we considered the possibility that Hand2 directly 
regulates VegfR3 expression. Using the previously described HeLa ChIP 
samples, we show that immunoprecipitation of Hand2-Myc/E12 transfected cell 
lysates results in selective enrichment of a region within the VegfR3 promoter 
that has been reported to have regulatory activity (Fig. 22A; Shawber et al., 
2007). Furthermore, by EMSA we show that Hand2 E12 heterodimers can 
specifically bind an oligo corresponding to one of the two E-boxes within this 
promoter region (Fig. 22B), which consists of the 500bp upstream of the VegfR3 
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translation start site. Finally, a luciferase reporter containing the mouse VegfR3 
promoter (-500/0), was repressed by Hand2 E12 heterodimers (~ 50% 
repression, Fig. 22C). Collectively these data indicate that Hand2 directly 





Figure 22: Hand2 directly regulates VegfR3 
ChIP of a region within the 500bp VegfR3 promoter (A). EMSA demonstrates Hand2 
E12 heterodimers can specifically bind an oligo corresponding to an E-box within the 
human VegfR3 promoter (B). Black arrow indicates E12 binding, red arrow indicates 
Hand2 E12 heterodimer binding, and blue arrow indicates nonspecific binding. 
Hand2 E12 heterodimers repress a luciferase reporter containing the homologous 
mouse 500bp VegfR3 promoter (C). Error bars denote standard error; asterisk 
denotes significant difference from pcDNA control.  
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Similar to several extracardiac angiogenic models of Notch signaling 
obstruction (Benedito et al., 2012; Hellstrom et al., 2007; Larrivee et al., 2012; 
Tammela et al., 2008), we show that endocardial Hand2 ablation results in a 
hyper-vascularization phenotype featuring the formation of an excessive number 
of new vessels. Furthermore, we show that this phenotype is accompanied by 
broad dysregulation of Vegf signaling. Homeostasis of Vegf signaling is crucial 
during embryonic development, as mice heterozygous for a VegfA null mutation 
die at E9.5, while an increase in VegfA expression (~3 fold) results in lethality at 
approximately E13.5 (Miquerol et al., 2000). Given the alterations observed in 
expression of VegfA, VegfD, VegfR2, VegfR3, and Nrp1 within H2CKOs, 
dysregulation of Vegf signaling and a consequential defect in endocardial 
maturation most likely account for the observed coronary phenotype. These data 
not only provide insight into a second novel function of Hand2 within the 
endocardium, but also reveal a wider role of Notch signaling during coronary 
vessel development. Coronary heart disease is a major cause of mortality in 
developed nations, being responsible for approximately one of every six deaths 
in the United States (Go et al., 2013). As such, there is great interest in better 
understanding the molecular processes that regulate coronary formation and 
function. While much remains to be done, the results of this study bring us one 
step closer to the depth of understanding that will be necessary if we are to 
engineer efficacious treatments. 
Collectively, our data reveal multiple novel roles for Hand2 in the 
endocardium where loss-of-function results in a TA phenotype. Histological analyses 
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indicate that the observed TA is a direct result of aberrant septal morphogenesis. We 
show that Hand2 participates in both endocardium-to-myocardium and endocardium-
to-endocardium based Notch signaling, with striking phenotypes associated with 
dysfunction. Endocardial Hand2 expression is regulated by Notch1 via EfnB2, and 
directly activates production of the crucial secreted growth factor Nrg1. In addition, 
Hand2 mediates proper development of the coronary vasculature by modulating Vegf 
signaling. Importantly, these studies suggest that mutations in the HAND2 locus, as 
well as additional components of endocardial Notch signaling, are a possible cause 
of TA in humans. Additional studies will be necessary to fully elucidate the 
contribution of endocardial Hand2 dysfunction to disease. 
Deletion of Hand2 from mesenchymal cells of the cardiac cushions at 
E11.5, well after initiation of Hand2 expression in endocardial precursors, does 
not result in any cardiac valve phenotypic abnormalities. This data supports a 
model in which essential Hand2 function lies within the ventricular endocardium. 
Hand2 expression within the early stage cushion mesenchyme is gradually 
downregulated, and by E18.5, Hand2 expression within the valves is restricted to 
only the Postn-Cre-negative endothelium covering the valve surface. We 
conclude that Hand2 does not play a critical role in endocardium derived cushion 
cells post EMT. However, it is interesting that Hand2 expression is robustly 
sustained in overlying valve endocardium, particularly on the backside of valves 
(ventricular side of AV canal). These data do not rule out a possible non cell-
autonomous role in cushion remodeling, through endothelial to mesenchymal 




Hand2 Function in Neural Crest Cells 
A. Introduction 
From early to mid-gestation Hand2 is expressed within most cardiac cell 
populations, including the cNCC. Developmental analyses demonstrate that 
Hand2 regulates a large number of important processes in cNCCs. Targeted 
deletion of Hand2 in NCC derived tissues via the Wnt1-Cre results in embryonic 
lethality at E12.5 (Morikawa et al., 2007). However, pharmacological rescue with 
the -agonist isoproterenol allows for analysis of cardiovascular development to 
birth, as the primary cause of death is a reduction in catecholamine production 
within the sympathetic nervous system. In pharmacologically rescued embryos 
conditional ablation of Hand2 in NCC derived tissues results in alignment defects 
of the aortic arch arteries and OFT, resulting in DORV with associated VSD 
(Holler et al., 2010; Morikawa and Cserjesi, 2008). These phenotypic 
abnormalities are thought to be the result of defects in cell migration, cell-cell 
communication/adhesion, and cell cycle regulation. Histological analysis shows 
that fewer cNCC reach the OFT in mutants, and that more of the migrating cells 
travel independently, whereas cNCC of the control embryos seem to migrate as 
a coherent sheet. Interestingly, Hand2 function in zebrafish development is 
required for proper ECM remodeling and the subsequent migration of lateral 
plate mesodermal cells. Hand2 is thought to regulate this migratory event by 
maintaining matrix metalloproteinase (MMP) activity, resulting in the 
diminishment of laminin deposition and proper gut looping (Yin et al., 2010). 
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While it is not currently clear if Hand2 regulates ECM remodeling during NCC 
migration, a microarray screen of RNA collected from murine E10.5 Wnt1-Cre 
Hand2 conditional knockout whole hearts revealed a set of over 300 differentially 
regulated genes in the NCC specific Hand2 deletion embryos, and included 
Mmp14 (Holler et al., 2010). Other candidates related to cell migration included 
Pdgf, Itga9, Itgα4, Adam19 and Cx40. Cx40 was of particular interest since it is a 
component of cardiac gap junctions, which are major mediators of cell-cell 
communication in the developing heart. Interestingly, Cx40 was strongly 
expressed in wild-type cNCC, but was dramatically down-regulated in Hand2 
CKO cNCC. To determine if Hand2 directly binds the Cx40 putative promoter, 
chromatin immunoprecipitation assays were conducted on a Hand2 expressing 
rat cardiomyocyte cell line. This pull-down showed that Hand2 binds the proximal 
E-box-containing regions of the Cx40 promoter in vitro. Furthermore, a luciferase 
transactivation assay demonstrated that when co-transfected, Hand2 and its 
dimer partner E12 can modestly up-regulate Cx40-luciferase expression, 
suggesting that Hand2 regulates chemical and electrical cell-cell communication 
through transcriptional control of gap junction components.  
In addition to cNCC migration related factors, many cell cycle related 
genes are differentially expressed in Wnt1-Cre Hand2 CKOs (Holler et al., 2010). 
The most highly regulated of these genes (up 37 fold) was cyclin B1 interacting 
protein 1 (Ccnb1ip1), which is an ubiquitin ligase that promotes the degradation 
of cyclin B. While the details of its function during development remain unclear, 
recent malignancy related research suggests that Ccnb1ip1 plays a role in 
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coordinating the cell cycle with cell migration and invasion (Singh et al., 2007) – 
functions required for OFT septation and valve formation. Others included cdk6, 
a serine/threonine kinase that regulates the G0 to G1 transition by 
phosphorylating retinoblastoma protein (Malumbres and Barbacid, 2005), Insm1, 
a regulator of NCC derived sympathetic neuron development which also interacts 
with cyclin D1 in the heart (Liu et al., 2006; Pellegrino et al., 2011), and several 
histones. Interestingly, a number of genes already associated with various 
aspects of cardiovascular development were found to be differentially regulated 
in the Wnt1-Cre Hand2 CKO mice. One down-regulated candidate that was 
particularly interesting was Sox11, since Sox11 null embryos develop DORV and 
associated VSDs as well as other OFT defects (Sock et al., 2004). Additional 
differentially regulated genes include the transcription factor Foxc1, the Notch 
downstream bHLH affecter and potential Hand dimer partner Hey1 (Firulli et al., 
2000; Firulli et al., 2007; Kokubo et al., 2005), the metalloproteinases MMP14 
and Adam19, which are critical for tissue remodeling, and NF-ATc2 which 
induces NF-ATc1. NF-ATc1 has key functions within the endocardium where 
Hand2 is also expressed (Zhou et al., 2002). Collagen type XI a1 (Col11a1), 
which is expressed in non-cartilaginous heart tissue, has been implicated in valve 
development (Peacock et al., 2008), while the latent transforming growth factor 
beta binding protein 1 (Ltbp1), has also been implicated in various aspects of 
cardiogenesis, including OFT septation, endocardial cushion EMT, and valve 
remodeling (Todorovic et al., 2011). Significantly, both Col11a1 and Ltbp1 are 
down-regulated in the Wnt1-Cre Hand2 CKOs. The Sonic Hedgehog (Shh) 
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signaling repressor Gli3 was also down-regulated. GLI3 mutations in humans are 
associated with isolated VSDs (Qiu et al., 2006). Interestingly, Gli3 is 
downstream of Hand2 within the developing limb (Charite et al., 2000). During 
limb morphogenesis, Hand2 restricts Gli3 expression to anterior mesenchyme, 
while Gli3 restricts Hand2 to the posterior limb mesenchyme. This genetic 
interaction establishes a Shh/FGF signaling feedback loop that is essential for 
proper limb patterning (te Welscher et al., 2002). Since Shh has been 
demonstrated to be necessary for normal OFT development (Washington Smoak 
et al., 2005), it is possible that Hand2 plays a similar role within cNCC. Given the 
number of transcripts regulated and the range of developmental processes they 
are known to function in, it is clear that Hand2 plays an important role in cNCC 
development. In order to more precisely define this role, additional experiments, 
such as Hand2 ChIP-seq, are required to determine which genes are regulated 
directly by Hand2, and which are regulated by as of yet unidentified 
intermediates. 
 
Hand2 function within NCC derived components of the ANS 
In addition to cNCCs, Hand2 is widely expressed in NCC derived 
components of the ANS. The ANS consists of the sympathetic, parasympathetic, 
and enteric nervous systems. In the past decade several loss of function genetic 
models have been employed to identify Hand2 functions within the ANS, with 
critical roles being identified within both the sympathetic nervous system and the 
enteric nervous system. Zebrafish Hand2 deletion mutants (hands off) display 
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appropriate generic neuronal differentiation, but noradrenergic differentiation of 
sympathetic ganglia is impaired (Lucas et al., 2006). In this model mutant 
sympathetic ganglia express Th and Dbh, two crucial catecholaminergic 
enzymes, at much lower levels than control ganglia. These results were 
recapitulated in a series of murine based studies which utilized the Wnt1-Cre to 
conditionally ablate Hand2 from NCCs (Hendershot et al., 2008; Morikawa and 
Cserjesi, 2008; Morikawa et al., 2007). As was previously mentioned, early 
ablation of Hand2 within the NCC lineage via the Wnt1-Cre results in embryonic 
lethality at E12.5. These studies conclude that Hand2 expression permits 
sympathetic neurons to acquire a catecholaminergic phenotype (Morikawa et al., 
2007), and this is accomplished by regulating the expression of transcription 
factors necessary for noradrenergic neuronal differentiation (Hendershot et al., 
2008). Furthermore, pharmacological rescue to birth with the -agonist 
isoproterenol convincingly demonstrates that early embryonic lethality can be 
attributed to noradrenergic deficiency (Morikawa and Cserjesi, 2008). However, 
these studies only identify ganglia of the sympathetic chain as sites of Hand2 
dependent catecholamine production. Catecholamines are synthesized at 
multiple additional sites, while Hand2 is expressed within a wide range of NCC 
derived structures. Given the aforementioned studies, it was not clear if 
catecholamine production at these additional sites is also Hand2 dependent.  
 Murine studies utilizing Wnt1-Cre and the enteric specific Nestin-Cre 
demonstrate that Hand2 function is required for many aspects of proper enteric 
development including neurogenesis, cell type specification, proliferation of 
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enteric precursor cells, and gangliogenesis (D'Autreaux et al., 2011; Hendershot 
et al., 2007; Lei and Howard, 2011). Enteric neurons do not produce 
catecholamines, but are essential for proper digestion. Ablation of Hand2 within 
enteric neural precursors via the Nestin-Cre, results in a severe bowel distention 
and death by approximately P20 (Lei and Howard, 2011). As Postn-Cre H2CKO 
mice die soon after birth (Table 2, Chapter 2), and the enhancer driving Postn-
Cre expression is known to be active in NCC derived components of the PNS 
(Lindsley et al., 2007), we sought to determine if enteric neurons, sympathetic 
ganglia, or additional sites of catecholamine synthesis were compromised in 
Postn-Cre H2CKOs.  
 
B. Methods  
Mice 
Generation of Postn-Cre(+); Hand2fx/fx embryos and genotyping was 
conducted as described in Chapter II. 
Section RNA In Situ Hybridization, quantitative RT-PCR, and Histological 
Preparations 
In situ hybridizations, qRT-PCR, and histology were conducted as described 
in Chapter II. 
Electrocardiograms 
ECGs were recorded and processed as described previously (Shen et al., 
2008). P3 pups were anesthetized with four percent isoflurane before electrode 
placement. Four percent isoflurane was continuously supplied via facemask and 
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environmental temperature was controlled via heat lamp. Electrodes were placed in 
both front legs and the left rear leg. Two ECG traces of approximately one minute in 
length were recorded for each pup, and the average heart rate was calculated. 
Results reflect n = 4; as previous studies have established that catecholamine 
insufficiency would only be expected to result in a decreased heart rate, p-value was 
calculated using a student’s one tailed t-test. 
 
C. Results 
In addition to AV valve mesenchyme, the Postn-Cre lineage includes NCC 
derived mesenchyme of the OFT valves. X-gal staining of embryos carrying a 
lacZ reporter confirmed that the Postn-Cre lineage overlaps with Hand2 
expression in OFT mesenchyme (Fig. 23A, B). Furthermore, Hand2 ISH 
demonstrated that Postn-Cre can effectively ablate this expression in E12.5 
H2CKO embryos (Fig. 23C). However, as with the endocardium-derived AV 
valves, analysis of OFT valves at E18.5 failed to reveal any remodeling defects. 
No differences in alcian blue staining were observed between control (Fig. 24A) 
and H2CKO (Fig. 24B) hearts, indicating that proteoglycan deposition is not 
impaired. Hand2 ISH once again demonstrates that Hand2 expression is 
restricted to endothelium overlying the valves (non-ventricular side of OFT 
valves) at late stages of embryogenesis (Fig. 24C, D). Furthermore, expression 




Figure 23: Postn-Cre mediated deletion of Hand2 from OFT cushions.  
Transverse section of Postn-Cre(+) lacZ stained control OFT cushion at E12.5 
(A). Hand2 ISH of control (B) and H2CKO (C) OFT cushion. Black arrows 
indicate cushion mesenchyme; brown arrows indicate primitive pulmonary valve. 





Figure 24: Postn-Cre H2CKO OFT valves are normal at E18.5. 
Alcian blue stained section of E18.5 control (A) and H2CKO (B) Aortic valve 
(AV). Hand2 ISH of control (C) and H2CKO (D) aortic valve. Postn ISH of control 





Postn-Cre ablates Hand2 from neurons of the enteric nervous system 
As Postn-Cre H2CKOs die soon after birth with a failure to thrive 
phenotype, similar to Nestin-Cre H2CKOs, we first looked for defects within the 
developing gut. Lineage tracing at E12.5 and E16.5 shows that Postn-Cre indeed 
marks the myenteric plexus in the stomachs and intestines of control (Fig. 25A, 
C) and H2CKO embryos (Fig. 25B, D). Similarly, ISH at E16.5 confirms previous 
reports (Hendershot et al., 2008; Lei and Howard, 2011; Wu and Howard, 2002) 
that Hand2 is also expressed within these enteric neurons (Fig. 25E). 
Furthermore, this expression is ablated in H2CKOs (Fig. 25F). To determine if 
this loss of Hand2 affects viability, we dissected out and visually assessed the 
gastrointestinal tracts of P3 pups (Fig. 25G). While deletion of Hand2 in enteric 
neural precursor cells results in gut obstruction and severe bowel distention by 
P20 (Lei and Howard, 2011), P3 Postn-Cre H2CKOs displayed a lack of fecal 
matter posterior to the cecal appendages (arrow Fig. 25G). This is indicative of 






Figure 25: Postn-Cre is co-expressed with Hand2 within the enteric nervous 
system. 
β-galactosidase stained sections of control and H2CKO stomachs at E12.5 (A, 
B), and E16.5 (C, D). Hand2 section ISH of control (E) and H2CKO (F) stomachs 
at E16.5. Dissected out gastrointestinal tract of control and H2CKO P3 pups (G). 
Arrows in (A,C) indicate myenteric plexus, arrow in (E) indicates Hand2 
expression within the myenteric plexus, (F) indicates deletion of Hand2. 
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H2CKOs display a loss of Dbh expression within sphenopalatine ganglia  
We next carefully compared Postn-Cre lineage with Hand2 expression in 
the sympathetic chain. Analysis of E12.5 embryos reveals robust Cre activity in 
components of the peripheral nervous system, as well as in and around the 
developing nasal cavity and maxilla (data not shown). As the Postn-Cre lineage 
is reported to include Schwann cells surrounding the sympathetic ganglia 
(Lindsley et al., 2007), we examined the sympathetic ganglia of H2CKOs at 
E12.5, when Wnt1-Cre generated H2CKOs die from lack of catecholamines 
(Hendershot, Liu et al. 2008). Postn-lineage analysis in transverse sections at the 
level of the heart confirms activation of the R26R reporter within the cells 
surrounding the sympathetic ganglia (Fig. 26B, C). Although the cells enveloping 
the trunk sympathetic ganglia were clearly marked, ISH demonstrates that 
expression of Hand2 (Fig. 26D, E) as well as Dbh (Fig. 26F, G), a gene known to 
be directly regulated by Hand2 (Rychlik et al., 2003; Xu et al., 2003), is 
unaffected when control and H2CKO embryos are compared.  
Interestingly, more detailed analyses of E12.5 heads reveal that the 
Postn-Cre lineage is not restricted to cells on the outer surface, but also marks 
the neurons within sphenopalatine ganglia (arrow; Fig. 26H). Despite being 
commonly considered parasympathetic and having a parasympathetic root, the 
sphenopalatine ganglia have an additional sympathetic root derived from the 
cervical sympathetic ganglia (Coppola et al., 2010). The sphenopalatine ganglia 
are known to express Dbh, with levels peaking at E12.5 and gradually being 





Figure 26: Postn-Cre mediates deletion of Hand2 within schwann cells of 
the sympathetic trunk and within the sphenopalatine ganglia at E12.5 
Schematic showing planes of section (A). β-galactosidase stained sections of 
control sympathetic ganglia (B, C). Hand2 ISH sections of control (D) and 
H2CKO (E) sympathetic ganglia. Dbh section ISH of control (F) and H2CKO (G) 
sympathetic ganglia. β-galactosidase stained frontal sections of sphenopalatine 
ganglia (arrow, H). Hand2 ISH of sphenopalatine ganglia in control (I), and 
H2CKO (J) embryos. Dbh ISH in control (K), and H2CKO (L) embryos. β-





sphenopalatine cells express TH and produce catecholamines, while most of the 
cells produce low levels of TH but do not produce catecholamines (Leblanc and 
Landis, 1989). Projections from the sphenopalatine ganglia are known to 
innervate the lacrimal gland, and regulate blood flow to the nasal mucosa, while 
additional evidence suggests a role in regulating cerebral blood flow (Suzuki et 
al., 1990; Ter Laan et al., 2013). ISH of frontal sections reveals that Hand2 is 
robustly expressed within the sphenopalatine ganglia of control embryos (Fig. 
26I), and its expression is ablated in H2CKOs (Fig. 26J). This loss of Hand2 is 
accompanied by a loss of Dbh, which is likely dependent on Hand2 function (Fig. 
26K, L). This data suggested that, despite normal Hand2 expression within the 
mid-gestation sympathetic trunk, neonatal H2CKOs may exhibit a reduction in 
catecholamine biosynthesis outside the sympathetic chain, or possibly within 
trunk ganglia due to a later stage deletion. We thus sought to examine additional 
tissues at later embryonic time points, to better define all of the sources of 
norepinephrine and epinephrine that might be compromised in H2CKOs. 
 
Late-stage Cre activity does not affect the sympathetic chain, but mediates 
deletion of Hand2 from the adrenal medulla 
To determine whether the Postn-Cre lineage, which is initially restricted to 
cells surrounding the trunk ganglia, later expands expression to include the 
ganglia neurons, ROSA reporter staining was conducted at E16.5. β-
galactosidase staining indicates that the Postn-Cre lineage includes only a small 
subpopulation of neurons within sympathetic trunk ganglia (Fig. 27A, B). 
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Importantly, Hand2 (data not shown) and Dbh (Fig. 27C, D) expression within the 
sympathetic trunk remains robust in H2CKOs. In the neonate and the adult, the 
adrenal medulla is the primary site for synthesis of circulating catecholamines 
(Malmejac, 1964). ROSA reporter staining at E16.5 indicates that Postn-Cre 
lineage includes cells of control (Fig. 27E) and H2CKO (Fig. 27F) adrenal 
medulla. Control and H2CKO adrenal glands were then collected from P3 pups, 
and analyzed by ISH. Hand2 (Fig. 27G) and Dbh (Fig. 27I) are both robustly 
expressed within control adrenal medulla at P3, whereas Postn-Cre efficiently 
ablates Hand2 (Fig. 27H), resulting in downregulation of Dbh (Fig. 27J), which 
would be expected to reduce catecholamine biosynthesis in H2CKOs. 
Furthermore, we confirmed these results by collecting additional P3 adrenal 
glands, isolating RNA, and conducting qRT-PCR. In H2CKOs Hand2 expression 
was reduced to approximately 7% of control levels (p-value = 0.004), while Dbh 
levels were reduced to approximately 11% (p-value = 0.023). Expression of Th, 
which encodes the enzyme responsible for conversion of L-tyrosine to a 
dopamine precursor, and Pnmt, which encodes the enzyme responsible for 
converting norepinephrine to epinephrine, was reduced to approximately 23% (p-








Figure 27: Expression of Dbh within sympathetic ganglia of H2CKOs is 
maintained at late stages of embryonic development, but Postn-Cre does 
ablate Hand2 expression within the adrenal medulla, resulting in 
downregulation of Dbh, Th, and Pnmt. 
β-galactosidase stained sections of control sympathetic trunk ganglia (A) and 
magnification (B) at E16.5. Dbh ISH of H2CKO sympathetic trunk ganglia (C), 
and magnification (D) at E16.5. Arrows in (B, D) indicate ganglia. β-galactosidase 
stained sections of control (E), and H2CKO (F) adrenal medulla at E16.5. Hand2 
ISH of control (G) and H2CKO (H) adrenal medulla at P3. Dbh ISH of control (I) 
and H2CKO (J) adrenal medulla at P3. qRT-PCR of Hand2, Dbh, Th, and Pnmt 
in isolated P3 adrenal glands (K). Asterisks in (H, J) indicate reduction of Hand2 







Postn-Cre H2CKO Pups exhibit bradycardia 
When observing H2CKO pups, it is clear that the animals are significantly 
smaller by P3 and exhibit a failure to thrive (Fig. 28A). Given the lack of cardiac 
structural defects, and the identification of multiple catecholaminergic Hand2-
expressing cell populations that overlap with the Postn-Cre lineage, a 
catecholamine deficiency in conjunction with gastrointestinal dysfunction is the 
most likely cause of the lethal failure to thrive phenotype. As catecholaminergic 
stimulation is essential for proper cardiac function, we tested this hypothesis by 
conducting electrocardiograms (ECGs) on P3 pups, and thereby assessing heart 
rates. After assessing four mutants, and an equal number of littermate controls 
(Fig. 28B, C), we determined that Postn-Cre H2CKOs had significantly slower 
sinus node rates (P-value = 0.019, Fig. 28D), a condition commonly referred to 
as bradycardia. Control pups averaged 466 beats per minute (bpm), while Postn-
Cre H2CKOs averaged only 337 bpm. In addition to heart rate, the ECG traces 
were used to calculate the average amount of time between the start of atrial 
activation and the start of ventricular activation (PR interval), but no significant 
difference was noted (Fig. 28E). Similarly, the duration of atrial depolarization (P-
wave duration), and duration of ventricular depolarization (QRS complex 
duration) were measured, with no significant difference found between controls 
and H2CKOs (Fig. 28E). To determine if H2CKOs were experiencing heart failure 
we examined expression of Nppa (atrial natriuretic factor; Anf), which becomes 
upregulated in ventricular muscle when undergoing stress (Edwards et al., 1988). 
Compared to the highly restricted atrial expression of Anf in control hearts (Fig. 
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28F) a clear marked increase in ventricular Anf expression is observed in 






Figure 28: Postn-Cre H2CKO pups have significantly slower heart rates and 
expanded Anf expression. 
H2CKO pups that survive to P3 are noticeably smaller than littermates (A). 
Representative ECG trace for P3 control (B) and H2CKO (C) pups. Panel (B) 
insert represents one cycle of cardiac contraction. Red bars denote the portion of 
the trace measured for P-wave duration, PR interval, and QRS complex duration 
as labeled. Control pups averaged 466 bpm, while H2CKO pups averaged 337 
bpm (D). P = p-value. Differences in average PR interval (ms), QRS complex 
duration (ms), and P wave duration (ms) between control and H2CKO P3 pups 










Hand2 expression and Postn-Cre lineage overlap within components of 
the enteric nervous system. Previous studies of enteric function show that 
ablation of Hand2 within enteric neural precursors via the Nestin-Cre, which is 
initiated by E11.5, results in a severe bowel distention by P20 (Lei and Howard, 
2011). The data in the current study show that Postn-Cre is initiated by E12.5, 
making it possible that Postn-Cre H2CKOs share the same gastrointestinal 
dysfunction as Nestin-Cre H2CKOs. Indeed, a lack of fecal matter posterior to 
cecal appendages of Postn-Cre H2CKOs indicates that decreased 
gastrointestinal motility could be contributing to neonatal lethality. Interestingly, 
this lack of motility resembles a human congenital motility disorder called 
Hirschsprung’s disease, which is pathologically characterized by a lack of enteric 
ganglia in a variable stretch of the distal bowel wall. While Postn-Cre H2CKOs do 
not appear to suffer from a complete loss of enteric ganglia (Fig. 25D), it is 
possible that a reduction in gangliogenesis within specific regions of the gut has 
evaded our detection. Indeed, as Nestin-Cre H2CKOs suffer from a functional 
aganglionosis (Lei and Howard, 2011), and the Postn-Cre enteric lineage closely 
resembles that of the Nestin-Cre, this would not be surprising; however, as the 
Nestin-Cre H2CKOs survive until P20, while H2CKOs generated by the Postn-
Cre do not, the involvement of additional non-enteric phenotypes is likely. 
This study demonstrates that, in addition to the established early 
embryonic roles Hand2 plays in cardiac morphogenesis and the development 
and function of the sympathetic ganglia, Hand2 plays important homeostatic 
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post-embryonic functions in the production of catecholamines. It is well 
established that Hand2 expression within the sympathetic chain is required for 
neurons to acquire and maintain a catecholaminergic phenotype (Hendershot et 
al., 2008; Schmidt et al., 2009). Loss of Hand2 within the sympathetic chain 
results in downregulation of the crucial biosynthetic enzymes Tyrosine 
Hydroxylase and Dbh (Hendershot et al., 2008). For a more complete description 
of Hand2’s role within the sympathetic nervous system, as established by various 
manipulations of Hand2 expression within multiple genetic systems, see (Table 
3). Our results confirm previous data showing that Postn-Cre expression is 
restricted to the cells surrounding sympathetic chain ganglia at E12.5 (Lindsley et 
al., 2007). As expected, Hand2 expression within the trunk sympathetic ganglia is 
unaffected in H2CKOs, at both E12.5 and E16.5. Dbh expression is similarly 
unaffected, indicating that trunk sympathetic ganglia in Postn-Cre H2CKOs 
produce sufficient concentrations of norepinephrine and epinephrine for 
embryonic survival to birth. However, we observed that Hand2 expression and 
the Postn-Cre lineage overlap within the sphenopalatine ganglia at E12.5, and 
ablation of Hand2 results in a dramatic decrease in Dbh expression in these 
ganglia. Given that the sphenopalatine ganglia is reported to have a sympathetic 
root derived from the superior cervical sympathetic ganglion, in addition to 
parasympathetic and sensory roots, the observation of Dbh downregulation is not 
surprising, and suggests that dysfunction within these ganglia could be 



















Retinoic acid treated P19-H2 cells but 
not P19-EC cells express peripherin (a 
peripheral nervous system marker), and 
a subset of these co-express Th. 
Ectopic Hand2 expression is 
able to activate the 
sympathetic nervous system 
developmental program within 
P19-EC cells. 





Sympathetic precursor cells aggregate 
to form normal sympathetic ganglion 
primordial, but th and dbh expression is 
strongly reduced 
Generic neuronal 
differentiation is unaffected, 
but noradrenergic 
differentiation of sympathetic 





Death at E12.5 with cardiovascular and 
craniofacial defects. Sites of 
sympathetic development are populated 
by neural crest cells, which express 
pan-neuronal markers. Th and Dbh 
expression is dramatically reduced. 
Hand2 permits sympathetic 
neurons to acquire a 
catecholaminergic phenotype 
(Hendershot 
et al., 2008) 
Mouse Wnt1-Cre 
Hand2 CKO 
See above; H2CKOs exhibit a 
significant and progressive loss of 
sympathetic neurons. 
Hand2 affects generation of 
the neural precursor pool by 
affecting proliferative capacity 
of progenitors and by 
regulating expression of 
transcription factors 







See above; early embryonic lethality 
could be rescued by administration of 
isoproterenol, a β-adrenoceptor agonist 
Noradrenergic deficiency 
alone accounts for early 





of Hand2 within 
differentiated 
sympathetic neurons 
by siRNA in cultured 
chick sympathetic 
neurons, and Dbh-
Cre in Hand2 
conditional mice 
Large decrease in Th and Dbh 
expression within Hand2 siRNA treated 
chick sympathetic neurons. Pan-
neuronal genes were not affected, while 
expression of cholinergic marker genes 
was enhanced. Dbh-Cre H2CKO mice 
showed decreased numbers of 
sympathetic neurons, and large 
reduction in Th expression 
Hand2 plays a key role in 
maintaining noradrenergic 




Interestingly, Hand2 expression and the Postn-Cre lineage overlap within 
the catecholaminergic cells of the adrenal medulla. Similar to what is observed in 
sphenopalatine ganglia, ablation of Hand2 within the adrenal medulla also results 
in a dramatic reduction of Dbh. ISH of H2CKO adrenal glands indicates that a 
small population of cells maintains Dbh expression, while the vast majority of 
expression within the adrenal medulla is lost. This is consistent with Hand2 loss 
of function studies within the sympathetic chain, where Dbh is known to be a 
direct Hand2 target (Rychlik et al., 2003; Vincentz et al., 2013; Xu et al., 2003). 
Furthermore, qRT-PCR shows that H2CKO adrenal glands exhibit significant 
decreases in Th and Pnmt, which like Dbh, encode enzymes that catalyze 
essential steps in the synthesis of the catecholamine adrenalin. In a study of 
Dbh-/- embryos, it was stated that while most die in utero, approximately 12% 
survive until birth. The 12% survival was attributed to a flow of catecholamines 
across the placenta, thus also explaining why of those that survive to birth, 40% 
die by P2 (Thomas et al., 1995). These data make it tempting to consider that 
Postn-Cre H2CKOs may have enough catecholaminergic biosynthetic capability 
to survive to birth as a result of unaffected sympathetic chain ganglia and 
supplementation from the mother, but at birth this supplementation ceases, 
leading to lethal catecholamine deficiency. It is well established that the adrenal 
medulla is a particularly important source of catecholamines that regulate heart 
rate, blood pressure, blood vessel constriction, and other critical aspects of 
cardiovascular function (Axelrod and Reisine, 1984; Fung et al., 2008). These 
data suggest that catecholamine deficiency, in conjunction with an enteric 
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phenotype, causes H2CKO postnatal lethality. Heart rates in H2CKOs are 
significantly slower than control littermates. This phenotype is consistent with 
previous publications on genetic models of catecholamine deficiency, such as 
Epas1 null mice, which are reported to have low catecholamine levels and a 
pronounced bradycardia (Tian et al., 1998), as well as Th null embryos, which 
are reported to have a 28% reduction in heart rate (Ream et al., 2008). In 
contrast, no difference in PR interval was observed between controls and 
H2CKOs, and while P-wave duration and QRS complex duration both trended 
toward an increase, no significant differences were observed, indicating that 
conditional ablation of Hand2 does not alter dromotropic properties of the P3 
heart. The reason for the differential effects of Hand2 deficiency on chronotropy 
versus dromotropy is unclear. It may involve differential expression of beta-
adrenergic receptors and/or their downstream targets in sinoatrial nodal cells 
versus cells of the cardiac specific conduction system. The decreased heart rates 
observed in P3 H2CKOs support the conclusion that a catecholaminergic 
insufficiency, in addition to enteric dysfunction, results in the neonatal H2CKO 
failure to thrive. In further support of this conclusion, upregulation of ventricular 
Anf expression in H2CKO hearts indicates pathological changes within these 





Conclusions and Future Directions 
The bHLH transcription factor Hand2 is widely expressed during 
embryonic development, and systemic deletion has convincingly demonstrated 
its essential nature. However, Hand2 expression is not ubiquitous, and the tissue 
specific nature of Hand2 function is only just beginning to be understood. This 
dissertation project addresses novel tissue specific loss- and gain-of-function 
experiments that are necessary to fully understand the dynamic and essential 
role for Hand2 in the developing heart. A firm understanding of the lineage 
specific roles that Hand2, as well as other Twist family transcription factors, play 
during embryonic development will be indispensable when analyzing how 
transcription factor dysfunction leads to congenital disease. 
Hand2 is robustly expressed within the embryonic endocardium, and its 
role within this tissue has not been previously studied. The data presented above 
establishes a functional requirement for Hand2 within the endocardium via a 
Notch-dependent mechanism. Hand2 conditional knockout within the 
endothelium (Tie2-Cre) or endocardium (Nfatc1Cre) results in embryonic lethality 
by E14.5 due to severe cardiac defects. H2CKO hearts display pronounced 
hypotrabeculation, aberrant septation, and absence of a direct connection 
between the RA and RV, closely phenocopying the human congenital disease 
TA. Nrg1 encodes a secreted signaling ligand, which is crucial for proper cardiac 
trabeculation and, in the endocardium, is regulated through Notch signaling via 
the ligand EfnB2. Nrg1 expression is greatly reduced in H2CKO endocardium; 
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however, EfnB2 expression is unaffected. DNA-binding and trans-activation 
assays demonstrate that Hand2 regulation of Nrg1 is direct, via interaction with 
the Nrg1 promoter. Additional genetic studies reveal that Hand2 functions directly 
within the Notch signaling pathway. The endocardium of embryos lacking either 
the Notch pathway effector RBPJk, or EfnB2 fails to express Hand2 and Nrg1. 
Collectively, these data establish Hand2 as an integral component of 
endocardial-myocardial Notch signaling, functioning downstream of EfnB2, and 
upstream of Nrg1 to regulate trabeculation and septal morphogenesis.  
We have established endocardial Hand2 as a downstream effector of 
Notch signaling. As the coronary endothelium derives at least in part from the 
endocardium via angiogenesis, and as Notch signaling is a known potent 
regulator of angiogenesis, we analyzed coronary angiogenesis and vascular 
gene expression in H2CKOs. H2CKO embryos display precocious formation of 
the coronary angiogenic plexus. Interestingly, gene expression analyses of 
H2CKO hearts at E10.5, prior to plexus formation, reveals that VegfR2, its co-
receptor Nrp1, and VegfD are all downregulated. In addition, analysis of E13.5 
hearts reveals that H2CKOs fail to downregulate Lyve-1 within the ventricular 
endocardium, indicating that dysregulated Vegf signaling results in defective 
endocardial maturation. Likewise, increased expression of VegfA and VegfR3 
within E13.5 H2CKOs may reflect a failure to downregulate expression from 
elevated levels present during earlier stages of cardiac development. VegfA is 
strongly pro-angiogenic, and likely accounts for the precocious coronary 
development observed in H2CKOs.  
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Postn-Cre H2CKOs survive till birth, but fail to thrive and die soon after. 
While our analyses reveal an absence of cardiac or sympathetic chain 
phenotypes, Hand2 is clearly ablated from the adrenal medulla and 
sphenopalatine ganglia where, similar to the sympathetic trunk, Hand2 plays an 
important role in regulating Dbh expression. The reduction of Dbh, Th, and Pnmt 
in H2CKOs indicates that pups likely have a decreased ability to synthesize 
catecholamines, resulting in the observed postnatal lethality. As 
catecholaminergic sympathetic stimulation is essential for proper cardiac 
function, ECG data showing that P3 H2CKOs have slower heart rates than 
control littermates, and upregulation of Anf within the ventricles of H2CKOs, 
supports this conclusion.  
This dissertation project has revealed several novel aspects of Hand2 
function, however, many interesting questions remain, particularly in regards to 
Hand2 function within the endocardium. Hand2 is commonly considered to 
primarily function within the myocardium, but in this study we conclusively 
demonstrate that Hand2 plays crucial functions within embryonic endocardium. 
However, Hand2 expression and function within the endocardium after birth has 
not been assessed. In chapter II we demonstrate that by E18.5 endocardial 
Hand2 expression is restricted to endothelium overlying the cardiac valves. It is 
unknown whether this expression persists into adulthood, or is gradually lost after 
birth. Even if this expression is lost, an interesting question remains: what 
function, if any, does Hand2 carry out within valve endothelial cells during late 
stages of embryonic development? The preferential expression of Hand2 on the 
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back side of OFT and AV valves suggests that Hand2 may be involved in setting 
up the distinct layers (ventricularis/atrialis, spongiosa, fibrosa) observed in 
mature valves. However, due to embryonic lethality in Tie2-Cre and Nfatc1Cre 
H2CKOs, alternative avenues such as utilization of the inducible endothelial 
specific VE-cadherin-CreERT2 recombinase (Monvoisin et al., 2006) will need to 
be explored. Also of interest, Notch signaling is reportedly activated within adult 
mouse hearts in response to injury (Gude et al., 2008; Øie et al., 2010). While 
myocardial Hand2 expression is also induced in failing hearts (Dirkx et al., 2013), 
a careful examination of endocardial Hand2 expression has not been conducted. 
If endocardial Hand2 is activated, it would be interesting to determine what role, if 
any, it plays in the response of the vasculature to ischemic injury. 
The data presented in the current study conclusively demonstrate 
dysregulation of Vegf signaling in endocardial H2CKOs. However, the complex 
interconnected nature of Vegf signaling makes determining which effects are 
primary and which are secondary extremely challenging. Solving this puzzle will 
require a combination of approaches, including genome wide analysis of Hand2 
transcriptional targets via ChIP-Seq, and analysis of protein-protein interactions 
with other endothelial related bHLH factors such as Hey proteins and Hif1α. This 
work is currently underway. Another key to sorting out primary and secondary 
effects will be improving our understanding of the expression profiles of genes 
dysregulated in H2CKOs. The expression profiles of many vascular related 
genes are poorly characterized within the heart, complicating data interpretation. 
Furthermore, upregulated genes may be ectopically expressed within cardiac 
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tissues that would not otherwise express them. In the current study we have 
analyzed the expression profiles of the most compelling genes discovered to be 
differentially expressed at the relevant time-points, but additional work remains. 
These experiments are also underway, and together with unbiased sequencing 
based assays will provide additional mechanistic insight into Hand2 regulation of 






Appendix I: Hand2 Function in the Epicardium 
In contrast to Hand1, Hand2 is robustly expressed within the PEO and 
epicardium during cardiovascular development but is undetectable within 
epicardial precursors that reside in the septum transversum, placing Hand1 
temporally upstream of Hand2 in this tissue. Recently, Hand1eGFPCre was used to 
conditionally delete Hand2 from Hand1 expressing cells within the septum 
transversum, as well as their derivatives (Barnes et al., 2011). H2CKOs display 
defects in epicardial EMT, a deficiency of cardiac fibroblasts, and increased 
epicardial apoptosis which results in an incompetent coronary vasculature that 
leads to embryonic lethality by E14.5 (Barnes et al., 2011). This phenotype is 
recapitulated by E9.5 deletion of Hand2 using the tamoxifen-inducible WT1ERT2Cre 
allele, which mediates ablation of Hand2 from the septum transversum, PEO, 
and lateral mesoderm (Barnes et al., 2011; Zhou et al., 2008). Gene expression 
analysis of primary epicardial cell cultures from Hand1eGFPCre H2CKOs revealed 
increased levels of the fibronectin receptor Itgα4 (also shown to be effected in 
NCC Hand2 ablation studies) and a greatly lowered ratio of PDGFRα to 
PDGFRβ.  Interestingly, platelet derived growth factor receptors have been 
previously shown to function in cell fate and specification of the epicardium after 
secondary EMT. Epicardial cells expressing PDGFRα derive into cardiac 
fibroblasts where PDGFRβ is associated with differentiation into coronary smooth 
muscle (Smith et al., 2011)  H2CKOs show marked reduction in PDGFRα 
expression as well as reduced numbers of cardiac fibroblasts. Hand2 regulation 
of PDGFRα regulation is direct, as luciferase assays demonstrated that Hand2 
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was able to transactivate the PDGFRα promoter (Barnes et al., 2011). These 
data support a novel role for Hand2 in specification of epicardial cell fates post-
secondary EMT.  
In addition to modified PDGFR signaling and cell fate, Hand2 plays a role 
in the ECM by modulating fibronectin assembly. Fibronectin is normally 
assembled into a complex structural network, which anchors cell and ECM 
adhesion molecules such as integrins (Pae et al., 2008). In wild type epicardial 
explants fibronectin is organized into neat bundles that facilitate these 
interactions, influencing actin dynamics, EMT, and the cell cycle. In addition, 
fibronectin regulates the stability and availability of extracellular matrix related 
factors, such as Tgfβ proteins and growth factors (Leiss et al., 2008; Sottile et al., 
1998). Although transcriptional and protein levels of fibronectin are unaltered in 
Hand2 epicardial CKO mice, fibronectin organization in mutant explants is 
abnormally uniform and sheet-like (Barnes et al., 2011). Furthermore, the 
fibronectin cell surface receptor Itgα4 is significantly upregulated in H2CKO 
explant cultures. Itgα4 is thought to play a role in adhesion of the epicardium to 
the underlying myocardium via interaction with vascular cell adhesion molecule 1 
(VCAM-1), which is reciprocally expressed with Itgα4 during cardiogenesis (Kwee 
et al., 1995; Pinco et al., 2001; Yang et al., 1995). This suggests that the 
combination of fibronectin disarray and transcriptional dysregulation of 
downstream signaling and adhesion components could be a key mediator of the 
Hand2 epicardial CKO phenotype. Studies in zebrafish have complemented 
these observations. In wild type zebrafish embryos, fibronectin deposition is 
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restricted to the basal surface of myocardial precursors, while in Hand2 mutants, 
fibronectin assembly is disorganized and no longer localized to a single surface 
(Trinh et al., 2005). Unfortunately, how Hand2 regulates fibronectin assembly is 
not yet known. Recent research in zebrafish demonstrated that fibronectin 
deposition at the midline is initially required for temporally correct migration of 
myocardial precursors (Trinh and Stainier, 2004), and that Hand2 
transcriptionally downregulates fibronectin expression, to create an environment 
conducive to fusion of these precursors at the midline (Garavito-Aguilar et al., 
2010). These studies indicate that Hand2 plays an important non-cell 
autonomous role in zebrafish cardiac development by transcriptionally 
modulating fibronectin expression and deposition. 
 
Ablation of Hand2 from the epicardium via Wt1-Cre 
In mice, early deletion of Hand2 from epicardial precursors via either the 
tamoxifen-inducible WT1ERT2Cre allele or Hand1eGFPCre results in several distinct 
phenotypes. These data, in addition to the reported zebrafish phenotypes, 
suggest that Hand2 may play both an early role in epicardial precursors, and a 
later role in the maturation of epicardial derivatives. To further temporally define 
when Hand2 function is required within the epicardial lineage, and to avoid 
potential confounding effects associated with tamoxifen injections, we utilized a 
transgenic non-inducible WT1-Cre allele (Kolander et al., 2014). In contrast to the 
Hand1eGFPCre, this Cre allele does not activate within the septum transversum. 
Furthermore, it marks only a subpopulation of the PEO, and all cells of the 
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epicardium. Upon crossing Wt1-Cre(+); Hand2fx/+ males with Hand2fx/fx; R26Rz/z 
females, embryos were collected and Xgal stained at E9.5 and E11.5. At E9.5 we 
observed recombination within a subpopulation of the PEO (Fig. 29A-D), and by 
E11.5 all epicardial cells were marked (Fig. 29E-H). Surprisingly, unlike 
Hand1eGFPCre and WT1ERT2Cre H2CKOs, Wt1-Cre H2CKOs were viable and 





Figure 29: WT1-Cre transgene mediates recombination in a PEO 
subpopulation and the epicardium 
R26R lacZ stained E9.5 control and H2CKO embryos (A, B). Sagittal sections of 
lacZ stained control and H2CKO E9.5 hearts (C, D). Black arrows indicate PEO. 
R26R lacZ stained E11.5 control and H2CKO embryos (E, F). Transverse 





Both Hand1eGFPCre and WT1ERT2Cre mediated deletion of Hand2 results in 
severe morphogenetic defects and early embryonic lethality. Surprisingly Wt1-
Cre H2CKOs do not recapitulate these defects. As both the Hand1eGFPCre and 
WT1ERT2Cre lineages mark early epicardial precursors within the septum 
transversum, while the Wt1-Cre does not, this may indicate that Hand2 function 
is required earlier in the process of epicardialization than was previously thought. 
While ISH does not readily reveal Hand2 expression within the septum 
transversum, a low but biologically essential level of expression cannot be ruled 
out. Alternatively, or perhaps in addition to this possibility, the Wt1-Cre H2CKOs 
contained two floxed Hand2 alleles (Wt1-Cre(+); Hand2fx/fx), while Hand1eGFPCre 
and WT1ERT2Cre H2CKOs contained only one (Cre+; Hand2fx/-). The requirement 
for Wt1-Cre to recombine both alleles may have temporally delayed the reduction 
in Hand2 gene dosage, thus alleviating the effects. Regardless, Hand2 does not 
appear to play essential roles in the epicardium after E11.5, when the R26RZ 
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